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Abstract
Large-scale genome-wide association studies (GWAS) have implicated thousands of germline variants in
modulating individual’s risk of diseases, including cancer. For low grade gliomas (LGGs), at least 25 risk
loci have been identified, whose molecular functions, however, remain largely unknown. Understanding how
the risk loci function in tumorigenesis poses a major challenge in the field, owing to potential confounding
factors and the lack of relevant types of experimental data in the brain. Based on statistical methods
and physics-inspired deep learning methods, this work presents a comprehensive computational framework
for performing functional analysis of LGG GWAS loci. We hypothesized that GWAS loci contain causal
single nucleotide polymorphisms (SNPs) which reside in accessible open chromatin regions and modulate the
expression of target genes by perturbing the binding affinity of transcription factors (TFs). We performed
an integrative analysis using genomic, epigenomic and transcriptomic data from public repositories and
identified the candidate (causal SNP, target gene, TF) triplets that might contribute to oncogenesis. We
assessed a candidate causal SNP’s potential regulatory role via convolutional neural network (CNN) and
simulated-annealing-based interpretation methods. Finally, we applied tensor train decomposition (TT-
decomposition) to neural network parameter reduction and demonstrated that the reduced convolutional
neural network performed well. This work helps understand the molecular mechanisms underlying genetic
risk factors of low grade glioma. The CNN and TT-decomposition-based deep learning approach may benefit
future functional genomic studies, where TF chromatin immunoprecipitation followed by sequencing (ChIP-
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1.1 Low grade glioma and the functional genomics
1.1.1 Human low grade glioma (LGG) and the IDH mutation
Glial cells are non-neuronal, supportive cells in the central nervous system and the peripheral nervous system
[1]. Astrocytes, oligodendrocytes, ependymal cells and microglia are the glial cells in the central nervous
system; Schwann cells and satellite cells are the glial cells in the peripheral nervous system. Gliomas are
tumors originating in the glial cells of the brain. About 30% of all brain and central nervous system tu-
mors are gliomas [2]. According to the 2016 World Health Organization (WHO) classification of tumors of
the central nervous system, gliomas include grade II diffuse astrocytomas, oligodendrogliomas, oligoastro-
cytomas; grade III anaplastic astrocytomas, anaplastic oligodendrogliomas, anaplastic oligoastrocytomas;
and grade IV glioblastomas [3]. Glioblastoma is also called glioblastoma multiforme (GBM), and is an ag-
gressive type of cancer. Low grade glioma (LGG) mainly includes diffuse astrocytic and oligodendroglial
tumors [3], and is less aggressive compared to GBM. Patients with low grade glioma have overall better
survival. The 2016 WHO classification further incorporated molecular features such as the mutations in
either isocitrate dehydrogenase 1 (IDH1 ) or isocitrate dehydrogenase 2 (IDH2 ) (collectively referred to as
IDH mut) and codeletion of the chromosome arms 1p and 19q (1p/19q codeletion). By including the status
of telomerase reverse transcriptase (TERT ) promoter mutations, gliomas can be further classified into five
main molecular groups based on the presence or absence of the three molecular alterations [4]. The five
molecular groups are “TERT promoter mutation only”, “IDH mut only”, “TERT promoter and IDH mut”,
triple-positive (IDH mut, TERT promoter mutant, 1p/19q codeleted) and triple-negative (IDH wild-type,
TERT wild-type, 1p/19q non-codeleted). The triple-positive and “IDH mut only” groups compose the major-
ity of LGGs, while “TERT promoter mutation only” is prevalent in glioblastoma multiforme [4]. This work
considers LGGs only, excluding GBM, with a focus on the triple-positive and “IDH mut only” groups, which
are usually oligodendrogliomas and astrocytomas, respectively, in terms of the 2016 WHO classification.
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Isocitrate dehydrogenases (IDHs) are important enzymes which catalyze the oxidative decarboxylation
of isocitrate to α-ketoglutarate (α-KG) [5]. IDH1 and IDH2 mutations have been observed in several types
of cancer, including glioma and human acute myeloid leukemia. In gliomas, IDH1 mutations typically
involve the amino acid substitution at codon 132, and are the most important and frequent mutations
in glioma. Furthermore, IDH1 mutation is considered as a driver mutation and is usually the first hit
in the development of astrocytomas and oligodendrogliomas [6]. The mutant IDH enzymes function by
producing 2-hydroxyglutarate (2-HG) from α-KG aberrantly, leading to a global hypermethylation phenotype
[7, 5, 8]. One study has shown that 19% of the analyzed 365,092 CpG sites were hypermethylated in
IDH mut gliomas compared to IDH wide-type gliomas [8]. Hypermethylation is known to alter the global
transcription; furthermore, it was also indicated to impact the chromatin topology. W. A Flavahan et al.
showed hypermethylation at CCCTC-binding factor (CTCF) binding sites in IDH mut gliomas, which led to
reduced CTCF binding [9]. CTCF is known to function as an insulator - it creates boundaries of domains
across the genome; elements inside those domains are considered to interact more frequently. Reduced
CTCF binding could alter the chromatin topology, and leads to aberrant gene expression. Specifically, the
study showed due to the loss of CTCF binding at a domain boundary, a constitutive enhancer interacted
with an important glioma oncogene platelet derived growth factor receptor alpha (PDGFRA), leading to
its increased expression [9]. All above have shown the huge impact caused by IDH mutations in gliomas.
Given the importance and potential impact of IDH mutations in low grade gliomas, we thus focus on the
triple-positive and “IDH mut only” subgroups in this study.
1.1.2 Genome-wide association study (GWAS)
Genome-wide association study (GWAS) is an observational study of genetic variants in large populations
to find out if any variant is associated with a trait. The genetic variant in a GWAS is usually a single-
nucleotide polymorphism (SNP), defined as the single nucleotide germline variant that occurs naturally at
some location of the genome (Figure 1.1). The traits in a GWAS are usually human diseases, including
cancer.
The first step of the genome-wide association study is to set up the case and control groups, and obtain
the allele counts for each SNP in the two groups. Then, to investigate if the allele frequency of one SNP
is significantly altered between the case and the control groups [10], odds ratio (OR) is utilized. The odds
ratio is defined as the ratio of the odds of one allele and the odds of another allele. Taking Figure 1.1 as an
example, the count of allele A in cancer (case) and healthy (control) groups are 30000 and 40000 respectively,
and the count of allele G in cancer (case) and healthy (control) groups are 40000 and 30000 respectively.
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The odds ratio for allele G in this example is (40000/30000)/(30000/40000). From the definition of odds
ratio, we could see that if one allele of a SNP is enriched in the case group compared to the control group,
the odds ratio for this allele is larger than 1; conversely, if the frequency of one allele is higher in the control
group compared to the case group, the odds ratio for this allele is smaller than 1.
Figure 1.1: An illustrative plot of single-nucleotide polymorphism (SNP) and an example of a 2 × 2 contin-
gency table in the genome-wide association study. The left panel: the base in the purple box represents a
SNP with Adenine (A) and Guanine (G) as its two alleles. For allele A of the SNP, it can be substituted by
allele G in either one chromosome or both chromosomes, resulting in AA, AG and GG genotypes. The right
panel: a 2×2 contingency table showing the allele count of A and G in cancer (case) and healthy (control)
groups.
Furthermore, people use P -value from the chi-squared test to assess the significance of the odds ratio
of a single SNP, and plot −log10(P -value) of every investigated SNP in a Manhattan plot (Figure 1.2).
The Manhattan plot depicts the SNPs that are significantly associated with a trait. The convention of the
P -value threshold to call a SNP significant is 5×10−8, due to hundreds of thousands of SNPs tested [10, 11].
To be noted, the significant SNPs discovered by the GWA studies are typically of low penetrance, and
are associated with a small increased risk of diseases. In our study, the median odds ratio for the 25 LGG
GWAS SNPs was 1.2, where 23 of the 25 SNPs had odds ratio less than 1.5, typical of low-penetrance genetic
variants [12] (Appendix A.1).
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Figure 1.2: An illustration of the Manhattan plot showing several loci significantly associated with LGG.
Figure is from Melin et al. [12]. The Y-axis is −log10(P -value) from the genome-wide discovery-phase
meta-analysis [12], and the X-axis is the genomic location. Each dot in the figure represents a SNP;
larger −log10(P -value) indicates stronger association. The red horizontal line denotes the P -value threshold
5×10−8. The LGG GWAS loci are highlighted by blue text and red text in the figure, where the red text
denotes the newly identified loci from Melin et al. [12].
1.1.3 The functional non-coding genome
The “central dogma” in molecular biology describes the flow of genetic information from DNA to RNA, then
to protein. The process of copying a segment of DNA to RNA is called transcription, and the process of
synthesizing amino acid sequences from RNA is called translation. In human, the whole genome has 23 pairs
of chromosomes and around 3 billion pairs of nucleotides. Among the 3 billion DNA base pairs, only 1% -
2% are protein coding regions, while the rest of the genome is the non-coding part. The non-coding genome
contains DNA sequences encoding certain types of RNAs, such as microRNAs (miRNAs) and long non-coding
RNAs (lncRNAs), all of which have important functions in the cell biological process. Moreover, the non-
coding genome contains various types of regulatory elements, for example, promoters, enhancers, silencers
and insulators, all of which play an essential role in regulating transcription. Promoters are typically located
around the transcription start site (TSS) of genes, and provide binding sites for transcription factors and RNA
polymerase to initiate transcription from DNA to RNA (Figure 1.3). Enhancers can be located upstream
or downstream of the regulated genes, sometimes even far away from their regulated genes. Enhancers also
provide binding sites for transcription factors, which modulate gene expression through interacting with
the protein complexes at the promoters (Figure 1.3). Promoters and enhancers are the most well studied
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TSS: Transcription start site. 
TF: Transcription factor. 
H3K4me3: Histone H3 lysine 4 tri-methylation.
H3K4me1: Histone H3 lysine 4 mono-methylation.
H3K27ac: Histone H3 lysine 27 acetylation.
Figure 1.3: An illustrative plot of two functional elements in the genome: promoter and enhancer. Promot-
ers and enhancers reside in open chromatin regions. Promoters could be marked by histone modification
H3K4me3; enhancers are usually marked by histone modifications H3K4me1 and H3K27ac. Enhancers can
interact with the protein complexes at the promoters to regulate gene transcription. Figure created based
on Calo and Wysocka [15].
Promoters and enhancers are marked by epigenetic modifications of the DNA packing proteins - histones.
Promoters are marked by the tri-methylation at the 4th lysine residue of the histone H3 protein (H3K4me3),
while enhancers are usually marked by the mono-methylation at the 4th lysine residue of the histone H3
protein (H3K4me1) and the acetylation of the 27th lysine residue of the histone H3 protein (H3K27ac)
(Figure 1.3). The genomic regions with histone modifications could be determined by one of the high-
throughput sequencing methods, named chromatin immunoprecipitation followed by sequencing (ChIP-seq).
ChIP-seq is also used to identify the binding sites of transcription factors (Section 1.1.4). In the ChIP-seq
procedure, the complexes of DNA segments and their bound transcription factors (TFs), or the complexes of
DNA and the chemically modified histone proteins (e.g., H3K4me1) are selectively pulled down by antibodies.
The DNA segments are then subjected to high-throughput sequencing to identify the transcription factor
binding sites or the sites with certain histone modification [16, 17] (Figure 1.4).
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Figure 1.4: An illustrative plot of the ChIP-seq procedure to identify the genomic locations of histone
modification or transcription factor binding sites. Figure from SequencEnG [18].
The promoters and enhancers reside in open chromatin regions (Figure 1.3), which can be identified by
methods such as DNase I hypersensitive sites sequencing (DNase-seq) and assay for transposase-accessible
chromatin using sequencing (ATAC-seq). In DNase-seq, we use DNase I enzyme, which preferentially cleaves
open chromatin regions, to obtain the DNase I digested DNA fragments, and then sequence them through
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high-throughput sequencing [19] (Figure 1.5A). For ATAC-seq, the open chromatin regions are obtained
through inserting the adapters using Tn5 transposase [20] (Figure 1.5B).
A B
Figure 1.5: An illustrative plot of (A) the DNase-seq and (B) the ATAC-seq methods to identify the open
chromatin regions in the genome. Figures are from SequencEnG [18].
As we know, the human chromatin folds to form 3D structures, which indicates that enhancers located
hundreds of thousands bases away may be spatially close to the promoters, and thus interact with them.
In order to capture the 3D structure of chromatin or the looping of chromatin mediated by a protein, Hi-C
[21], proximity ligation-assisted ChIP-seq (PLAC-seq) [22] and chromatin interaction analysis by paired-end
tag sequencing (ChIA-PET) [23] could be used.
It is crucial to understand that different cell types may have very divergent landscapes of the functional
non-coding genome. For example, the open chromatin regions and the transcription factor binding sites of
a glial cell could be very different from those of a blood cell. The functional analysis of the cell-type specific
non-coding regions has thus drawn tremendous research interest. Our work in this thesis is also based on
the functional annotations of the non-coding genome of brain cells.
1.1.4 Transcription factor (TF) and the DNA binding motif
Transcription factors (TFs) are proteins that bind to DNA sequences and regulate the transcription of
genes. TFs include activators and repressors, which function by promoting or blocking the transcription,
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respectively. The binding sites of transcription factors in the genome can be experimentally determined by
ChIP-seq. TF binding is highly sequence selective, i.e., different TFs recognize different DNA sequences
(referred to as motifs). The TF binding motif is often represented by a position-specific scoring matrix
(PSSM). The elements in the PSSM matrix are calculated as log likelihoods. Suppose a transcription factor
recognizes a motif of length L, the PSSM matrix is:
PSSM =

log2(pA,1/qA) log2(pA,2/qA) . . . log2(pA,L/qA)
log2(pC,1/qC) log2(pC,2/qC) . . . log2(pC,L/qC)
log2(pG,1/qG) log2(pG,2/qG) . . . log2(pG,L/qG)
log2(pT,1/qT ) log2(pT,2/qT ) . . . log2(pT,L/qT )

, (1.1)
where pi,j (i ∈ {A,C,G, T}, j ∈ {1, . . . , L}) is the frequency of nucleotide i at position j in N aligned
sequences of length L, and qi (i ∈ {A,C,G, T}) is the background frequency of nucleotide i. Using the
PSSM matrix of a TF, we could determine if a given sequence is likely to be bound by the TF.
The TF binding motif could also be represented by motif logos graphically (Figure 1.6). The height of
each position in the sequence logo is measured with the unit bit, and is equal to the Kullback–Leibler diver-
gence (KL-divergence) between the probability distribution of nucleotides at position j and the probability
distribution qi = 0.25 (i ∈ {A,C,G, T}):







The relative height of each nucleotide in the stack is proportional to its probability at the corresponding
position.
Figure 1.6: Motif logo of transcription factor MAFF (MA0495.1) from the JASPAR database [24]. The
Y-axis is in bits. The core binding motif (consensus sequence) is TCAGCA or its reverse complement
TGCTGA.
8
From the above introduction we could see that a single nucleotide change in a DNA sequence fragment
might perturb the binding affinity of corresponding transcription factors, and subsequently affect the ex-
pression of genes regulated by the TFs. A single nucleotide variation may also alter the chromatin topology.
Z. Tang et al. demonstrated that a single nucleotide variation disturbed the binding affinity of CTCF and
altered the CTCF-mediated chromatin looping [25].
1.1.5 Functional analysis of LGG GWAS variants
As mentioned in Section 1.1.2, recent large-scale genome-wide association studies have implicated at least
25 SNPs associated with the LGG susceptibility, but their molecular pathways remain elusive. Only few
studies have hitherto discovered the corresponding genes directly regulated by these SNPs [26, 27]. This
work is dedicated to find the causative consequences of the LGG GWAS SNPs, specifically, to decipher how
a single nucleotide change might contribute to the glioma phenotype.
Most of the LGG GWAS SNPs reside in the non-coding regions of the human genome, posing significant
challenges to revealing their molecular functions and identifying susceptibility genes that may inform pre-
ventive and therapeutic measures. Our main hypothesis is that the GWAS loci contain causal SNPs that
reside in the functional regulatory regions of the human genome and modulate the expression of target genes
by directly perturbing the binding affinity of TFs. To better understand the molecular functions of germline
variants in modulating LGG risk, we developed an integrative framework utilizing genomic, epigenomic and
transcriptomic data to identify candidate (causal SNP, target gene, transcription factor) triplets. The steps
are summarized as below, and the detailed integrative analysis pipeline for analyzing LGG GWAS SNPs is
presented in Chapter 2.
We first integrated genomic and epigenomic data from public databases, such as Encyclopedia of DNA
Elements (ENCODE) [17] and Roadmap Epigenomics Mapping Consortium (REMC) [28, 29], to identify
germline variants located in regulatory elements of the non-coding genome. We then performed expression
quantitative trait loci (eQTL) and phased allele specific expression (ASE) analyses on heterogeneous low-
grade glioma data from The Cancer Genome Atlas (TCGA) [30] to prioritize putative target genes of a given
GWAS SNP. At last, we performed in-silico TF binding sequence perturbation analysis and TF-target gene
expression correlation analysis, which implicated the transcription factors whose binding affinity might be
perturbed by putative causal SNPs. For the case study of 11q23.2 variant rs648044, experimental validation
was also performed.
We hope our proposed (causal SNP, target gene, transcription factor) triplets could facilitate additional
analysis or experimental validation. We also hope the integrative and systematic analysis of the LGG GWAS
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loci could help accelerate the discovery of molecular mechanisms underlying genetic risk factors for gliomas.
1.2 Deep learning applied to transcription factor binding
prediction
1.2.1 Convolutional neural network (CNN)
Convolutional neural network (CNN) has gained tremendous success in computer vision related fields. It has
shown prodigious ability in pattern recognition, class identification, image segmentation etc. An example of










Convolution-1 Pooling-1 Convolution-2 Pooling-2 Flatten
Fully connected
Figure 1.7: An example of a convolutional neural network.
A convolutional neural network typically includes a series of convolutional layers and pooling layers,
followed by the fully connected layers (Figure 1.7). The convolutional layer is the core structure of a
convolutional neural network. It consists of a set of convolutional filters which slide on the input signal. In
the forward pass, each filter is convolved with the input signal, yielding the dot product of the elements
of the filters with the input elements, and produce an activation map from the input. There are two
commonly used activation functions: Sigmoid function, expressed as σ(z) = 11+e−z ; ReLU function, expressed
as σ(z) = max(0, z) (Figure 1.8B). ReLU activition is usually used after the convolutional layers in a
convolutional neural network, while the sigmoid function is often used at the output layer. Between two
successive convolutional layers, we typically insert a pooling layer to down sample the results obtained from
the convolutional layer. Max pooling is the most commonly used pooling function. It segregates the input
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of the pooling layer into non-overlapping rectangular areas, and outputs the maximum number in each
rectangular area. After a set of convolutional and pooling layers, the fully connected layers are appended.
The fully connected layers in a CNN are essentially a “vanilla” artificial neural network (Figure 1.8A).
The fully connected layer transforms a high-dimensional input signal (denoted by x) to a high-dimensional
output signal (denoted by y) with a large dense matrix W, bias vector b and an activation function σ:
y = σ(Wx + b).
After choosing the loss function, stochastic gradient descent (SGD) or other optimization methods mod-
ified from SGD are utilized to train a convolutional neural network. For our CNN models (Chapter 4,







Hidden layer Output layer
W2
𝒚𝟏 = 𝜎"(𝑾𝟏𝒙 + 𝒃𝟏) 𝒚𝟐 = 𝜎$ 𝑾𝟐𝒚𝟏 + 𝒃𝟐
Loss	Function:













𝜎 𝑧 = 𝑚𝑎𝑥(0, 𝑧)
Sigmoid
ReLU
Figure 1.8: The basic structure of a feed forward neural network (A) and two commonly used activation
functions: Sigmoid and ReLU (B).
1.2.2 Deep learning methods for TF binding prediction
As mentioned in Section 1.1.4, transcription factors are proteins that bind to DNA sequences and regulate
gene transcription. A transcription factor recognizes a binding motif, and its binding sites are cell-type
specific due to the different landscape of different cells’ open chromatin regions. Experimentally, transcription
factor binding sites could be determined by ChIP-seq. Despite a large number of ChIP-seq experiments have
been performed, however, it is still not possible to obtain the ChIP-seq results for every transcription factor
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in every cell type. Thus, predicting cell-type specific transcription factor binding sites has become a challenge
and a research hotspot in bioinformatics.
Like other machine learning methods, deep learning methods have also been applied to transcription
factor binding prediction. Many previous deep learning approaches have been using sequence information
only, for example, the DeepBind model (Figure 1.9) [32]. Some recent studies have begun to utilize other
genomic and epigenomic information in the prediction, for example, the FactorNet model (Figure 1.10) [33].
In our deep learning model (Figure 2.5) to be detailed in Section 2.3.3 and Section 4.3, we integrated DNase-
seq signal with sequence information into one convolutional filter, and utilized the same set of convolutional
filters to scan the positive strand sequences as well as their reverse complements (Figure 2.5). We successfully
performed the allele-specific binding prediction for transcription factor SP1.
Figure 1.9: The DeepBind model, where the inputs are sequences only. Figure from B. Alipanahi et al. [32].
12
Figure 1.10: The FactorNet model, where the inputs include sequence information and open chromatin
information (DNase). Figure from D. Quang et al. [33].
1.3 Basics of tensor and tensor decomposition
Tensors can be viewed as multidimensional generalizations of vectors and matrices. Mathematically, tensor
is defined as a d-dimensional array: A = A(i1, . . . , id), where A denotes a tensor and ik (k = 1, . . . , d;
1 6 ik 6 nk) denotes the index of dimension. Tensor are widely used in various areas. When performing
tensor analysis, however, we often face the problem of curse of dimensionality, where memory and amount
of operations grows exponentially in dimension d [34]. To work with large dimensional problems, an efficient
representation of a tensor by a small number of parameters is thus needed.
There are different ways for performing tensor decomposition, for example, canonical polyadic decom-
position (CP decomposition) and higher-order singular value decomposition (HOSVD). Canonical polyadic
decomposition is also called tensor rank decomposition, and is a generalization of the matrix singular value
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decomposition (SVD) to tensors. Given a tensor A, CP decomposition is expressed as:
A(i1, . . . , id) =
r∑
α=1
U1(i1, α)U2(i2, α) . . . Ud(id, α), (1.3)
where r is the tensor rank, and represents the minimal summands to express A in equation 1.3; Uk =
[Uk(ik, α)] are called canonical factors [34]. Equation 1.3 is a good candidate for expressing high dimensional
tensor A in low-parametric format. However, there are several drawbacks when numerically computing such
an approximate representation: first, computing the tensor rank is an NP-hard problem [35, 34]; second, the
approximation of A in the Frobenius norm with a fixed tensor rank could be ill-posed [36, 34]; moreover, there
is a probability of being stuck in the local minima in the computation process [34]. Thus, it is numerically
difficult to get the best low-tensor-rank approximation of A. On the other hand, higher-order singular value
decomposition (HOSVD), which is an orthogonal format of Tucker decomposition [37, 38], provides a way
to decompose a tensor into a small core tensor and several matrices. Higher-order SVD of a given tensor A
is written as:
A = S×1 U(1) ×2 U(2) . . .×d U(d), (1.4)
where U(k) = (U
(k)
1 , . . . , U
(k)
nk ) is an nk × nk orthogonal matrix, and S is an “all-orthogonal” and ordered
core tensor. The truncated HOSVD of A, written as Â, is then obtained by discarding the first few left
singular vectors with the smallest singular values in HOSVD [39]. There are also several disadvantages of
higher-order SVD or Tucker decomposition: although the Tucker format is stable, its parameter number
O(dnr+ rd) depends on the exponent d, and thus is not suitable for large dimension cases [34]; unlike in the
matrix case, when performing tensor approximation using truncated HOSVD, the truncated approximation
may not be the best possible approximation that satisfies the n-mode rank 1 constraints [39].
All the above disadvantages of CP decomposition and the Tucker format motivate us to study a new
format of tensor decomposition, called tensor train decomposition, abbreviated as TT-decomposition. It is
also known as matrix product state (MPS) in theoretical condensed matter physics. A tensor A is said to
be in the tensor train format (TT-format) if element with index (i1, . . . , id) in tensor A is expressed as [34]:
A(i1, . . . , id) = G1(i1)G2(i2) . . . Gd(id), (1.5)
1n-mode rank (from [39]): Suppose the HOSVD of tensor A is expressed as A = S×1U(1)×2U(2) . . .×dU(d), and A(n) is the













where Rn, called the n-mode rank or n-rank, is the matrix rank of A(n).
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where Gk(ik) is an rk−1 × rk matrix, and r0 = rd = 1 [34]. It also can be written in the index form [34]:
A(i1, . . . , id) =
∑
β0...βd
G1(β0, i1, β1)G2(β1, i2, β2) . . . Gd(βd−1, id, βd). (1.6)
We will give the details of the TT-format of a given tensor in Chapter 6. Representing a tensor using the
TT-format is referred to as TT-decomposition.
There have been a number of applications of TT-decomposition. In Chapter 6, we will first review the
idea of applying TT-decomposition to neural network parameter reduction in the fully connected layer,
proposed by A. Novikov et al. [40], and then demonstrate the performance of the parameter-reduced CNN
of SP1. Similar to the idea of factorizing the fully connected layer [40], Y. Yang et al. applied tensor train
recurrent neural network to video classification [41]. In the work, the authors utilized TT-decomposition
to reduce the parameter number of the input-to-hidden mapping in the recurrent neural network model,
and demonstrated its competitive prediction accuracy with the state-of-art models in video classification. J.
Su et al. proposed a convolutional tensor-train decomposition model (CTTD), where convolutional kernels
were factorized into tensors, and applied CTTD to construct a convolutional tensor-train long short-term
memory (LSTM) model to capture long-term spatio-temporal correlations [42].
Tensors are not only widely used in various areas of computer sciences, but also heavily used in theoretical
condensed matter physics. For example, we could use tensor network methods to simulate strongly correlated
systems, and describe the wave function of the system as a network of tensors [43, 44, 45, 46]. Density matrix
renormalization group (DMRG) [47, 48, 49, 50] is another famous example of a tensor network method [46].
1.4 Overview
This work is dedicated to understand the molecular functions of germline genetic variants in modulating LGG
risk using statistics and physics-inspired deep learning methods. The thesis contains three interconnected
modules. In the first module, we present an integrative computational framework to identify the putative
(causal SNP, target gene, transcription factor) triplets that might contribute to LGG oncogenesis (Chapter
2). As case studies of detailed analysis and interpretation, we then focus on 3 loci that have (1) a target
gene with known tumor suppressor functions in other cancers (rs648044, ZBTB16 locus, Chapter 3), (2)
one of the lowest GWAS P -values (rs12803321, PHLDB1 locus, Chapter 4), and (3) no convincing eQTL
candidate gene in a previous study [12] (rs11706832, LRIG1 locus, Chapter 5), respectively. To better assess
the allele-specific binding pattern of the TF SP1 in the human brain, in the second module, we present a
deep learning approach based on convolutional neural network and simulated-annealing-based interpretation
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method (Chapter 4, Section 4.3). Inspired by the concept of tensor train decomposition, also known as
matrix product state in condensed matter physics, in the third module, we present the recent proposed
application of TT-decomposition to neural network parameter reduction, and demonstrate the performance
of the parameter-reduced convolutional neural network of SP1 (Chapter 6). We conclude this thesis with
Chapter 7, conclusion.
Our main results and methods from Chapter 2, 3, 4, 5 have been published in Neuro-oncology as a
research article: Manjunath†, Yan† et al., “Functional analysis of low-grade glioma genetic variants predicts
key target genes and transcription factors” (†co-first authors, contributed equally) [51]. The author of this
thesis also contributed to the LGG-related analysis in Zhang et al., “The cancer-associated genetic variant
rs3903072 modulates immune cells in the tumor microenvironment” [52], where the author performed eQTL
analysis in LGG and confirmed the negative association between the expression level of CTSW and the risk
genotype of a breast cancer GWAS SNP rs3903072 in low grade glioma. This helped to confirm the putative
role of rs3903072 in modulating the expression of CTSW, a candidate tumor suppressor, in tumor-infiltrating




Integrative analysis pipeline for LGG
GWAS SNPs
In this chapter, we present an integrative analysis pipeline for LGG GWAS loci. Most of the work presented in
this chapter has been published in Manjunath†, Yan† 1 et al., Neuro-oncology, 2020 [51]. The computational
part of the pipeline was developed in collaboration with Dr. Mohith Manjunath and Dr. Yi Zhang. The
experimental parts were performed by members of Professor Paul R. Selvin’s lab at UIUC, members of
Professor Robert B. Jenkins’s lab at Mayo Clinic and members of Professor Joseph Costello’s lab at UCSF.
To understand the functional impact of LGG GWAS variants, this framework integrated heterogeneous
genomic, epigenomic and transcriptomic high-throughput sequencing data, and incorporated computational,
experimental and deep learning approaches (Figure 2.1). The pipeline could be divided into three subsections:
putative causal SNP identification, target gene identification, and TF prioritization. We started with a list
of 25 GWAS SNPs that showed association with increased risk for LGG in the population (Table A.1,
Appendix A.1).
2.1 Putative causal SNP identification
The genome-wide association studies usually report the SNPs that are most significantly associated with
some trait (smallest P -values in GWAS) as the GWAS SNPs. However, the reported GWAS SNPs might not
necessarily be the functionally causal ones. We proposed that the nearby SNPs residing in open regulatory
chromatin regions and in high linkage disequilibrium (LD) with the GWAS SNPs could act as true molecular
effectors. We therefore examined all SNPs in high LD with the GWAS SNPs (r2 > 0.8, 1000 Genomes Phase
3, EUR population, Appendix A.1) along with the epigenomic information to identify the putative causal
ones.
1†co-first authors, contributed equally.
17
        H3K4me1, H3K27ac, ChromHMM
(REMC adult prefrontal cortex and fetal brain)
      PLAC-seq
(Oligodendrocytes)
               ATAC-seq
(TCGA LGG, Oligodendrocytes)
                         DNase-seq
(REMC adult prefrontal cortex and fetal brain)
            GWAS and High LD SNP
(1000 Genome Phase 3, Population EUR)
                       cis-eQTL
                 (LGG subgroups)
   Phased Allele Specific Expression
                 (LGG subgroups)
          Gene Expression Profile 




    TF and Target 
Genes Correlation 
        Analysis
Putative TFs
      Allele Specific TF 
     Binding Prediction
(Convolutional neural net) 
Convolutional Neural net 
     Learned Sequence
             Analysis
    (Simulated annealing) 
   Functional SNP - TF 
  - Target Gene Putative 
    Regulatory Network
Available TF ChIP-seq
   (Published datasets, 



















Figure 2.1: Integrated framework for functional analysis of LGG GWAS SNPs. Green: epigenomic data;
pink: genomic information; blue: transcriptomic data and analysis; purple: motif and TF-gene expression
correlation analyses; ocean blue: deep learning approaches for TF binding prediction; yellow: experimental
validation; red: candidate triplets.
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2.1.1 Epigenomic data
Epigenetic modifications, such as DNA methylation and histone modification, are reversible modifications
on DNA or histone without altering the sequence of DNA. They play an important role in modulating gene
expression and are involved in numerous cellular processes including tumorigenesis. Histone H3 lysine 4
mono-methylation (H3K4me1) and H3K27 acetylation (H3K27ac) are enriched at active enhancers, while
H3K4 tri-methylation (H3K4me3) is enriched at promoters. In order to select high LD SNPs residing in
regulatory enhancer regions of the brain genome, we examined H3K4me1 and H3K27ac chromatin immuno-
precipitation followed by sequencing (ChIP-seq) data from the fetal brain and dorsolateral prefrontal cortex.
Trained on a set of histone marks, ChromHMM [53] could capture the combinatorial interactions between
different histone marks; the trained model could then be used to calculate the posterior probability of each
chromatin state for different genomic regions. We therefore additionally utilized the processed ChromHMM
data tracks in our analysis.
We also assessed the open chromatin information given by assay for transposase-accessible chromatin
using sequencing (ATAC-seq) and DNase I hypersensitive sites sequencing (DNase-seq) as well as chromatin
interactions measured by proximity ligation-assisted ChIP-seq (PLAC-seq), to further prioritize the high LD
SNPs residing in accessible regulatory DNA elements in the human brain.
The epigenomic data sources are stated as below. We obtained histone modification (H3K4me1, H3K27ac)
ChIP-seq datasets of brain tissues, DNase-seq datasets of the fetal brain and ChromHMM [53] tracks of dif-
ferent tissues from the Roadmap Epigenomics Mapping Consortium (REMC) database [28, 29]. Primary
tumor ATAC-seq aligned BAM files of glioma patients were downloaded from the TCGA Data Portal [30],
and the normalized ATAC-seq BigWig files of glioma patients were obtained from Corces et al. [54]. The
processed ATAC-seq, H3K27ac and PLAC-seq data in oligodendrocytes were obtained from Nott et al. [55]
(https://genome.ucsc.edu/s/nottalexi/glassLab BrainCellTypes hg19).
2.1.2 Linkage disequilibrium and candidate causal SNPs
Linkage disequilibrium (LD) describes the non-random association of the alleles at two loci in one popu-
lation [56, 57]. The level of linkage disequilibrium is affected by natural selection, genetic drift, mutation,
recombination etc. [57] One of the measures used in the community to describe LD between two loci is r
squared (r2, 0 6 r2 6 1), where larger r2 denotes higher linkage disequilibrium. In human genetics, if two
SNPs are in high LD, the allele frequencies of these two SNPs are strongly associated, as illustrated by an
example in Figure 2.2. Thus, if one SNP is reported as GWAS SNP in genome-wide association studies,
its high LD SNPs are also likely significantly associated with the phenotype, although with slightly larger
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P -value compared to the GWAS SNP (Figure 2.3).
We therefore proposed that the nearby SNPs which reside in open regulatory chromatin regions and in
high linkage disequilibrium with the GWAS SNPs could act as true molecular effectors. We obtained all
SNPs in high LD with the GWAS SNPs (r2 > 0.8, 1000 Genomes Phase 3, EUR population, Appendix
A.1) using LDlink [58]. We then aligned all the high LD SNPs with the DNase-seq, ATAC-seq, PLAC-seq
H3K4me1 ChIP-seq and H3K27ac ChIP-seq signal tracks, and selected the SNPs that reside in the peaks of
the above-mentioned signals as putative causal SNPs.
Figure 2.2: A snapshot given by LDlink [58] of two high LD SNPs in EUR population. Haplotype
counts: rs7572263-A|rs7583625-A: 753; rs7572263-A|rs7583625-G: 8; rs7572263-G|rs7583625-A: 0; rs7572263-
G|rs7583625-G: 245. Allele frequencies: rs7572263-A: 0.756; rs7572263-G: 0.244; rs7583625-A: 0.749;
rs7583625-G: 0.251. r2 of these two SNPs: 0.9582. rs7572263-A allele is correlated with rs7583625-A
allele; rs7572263-G allele is correlated with rs7583625-G allele.
2.2 Target gene identification
We performed expression quantitative trait loci (eQTL) and phased allele specific expression (ASE) analyses
using The Cancer Genome Atlas (TCGA) genotype and gene expression profiles to identify putative target
genes.
2.2.1 TCGA LGG data
We utilized five types of TCGA LGG datasets [30]: germline genotype data of 513 patients, primary tumor
copy number segmentation data of 513 patients, tumor RNA-Seq aligned bam files of 516 patients, processed
gene-level RSEM (RNA-Seq by Expectation Maximization) expression data of 516 patients, and clinical
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Figure 2.3: The GWAS P -value landscape in the region around LGG GWAS SNP rs7572263. This figure
is Supplementary Fig. 3 of Melin et al., Nat. Genet., 2017 [12], and is shown here to illustrate the P -value
landscape of the reported GWAS SNP and its high LD SNPs. Y-axis on the left: − log10(P value from
GWAS); Y-axis on the right: genetic recombination rate, shown as light blue line in the figure; X-axis:
human NCBI build 37 Chromosome 2 positions; colored triangle or circle: genotyped (triangle) or imputed
(circle) SNPs with the color corresponding to the r2 of LD with the lead SNP (rs7572263). The genes
mapping to this region were also shown in the figure.
data of 515 patients. Out of 508 patients possessing all five data types, 427 patients’ molecular subtype
information was available [59, 60]. Assigning these 427 patients to the five molecular subgroups (“TERT
promoter mutation only”, “IDH mut only”, “TERT promoter mutant and IDH mut”, “triple-positive” and
“triple-negative”) yielded 204 patients in the “IDH mut only” subgroup and 137 patients in the “triple-
positive” subgroup.
2.2.2 Genotype imputation
Since genotype files from TCGA only provide the genotype calls of 906600 tag SNPs, we need to impute the
genotype and haploptype of all SNPs using imputation engines. The preparation of imputation input file
and the process of imputation results are stated as below.
We first obtained germline genotype data of 513 LGG patients in the birdseed format from the TCGA
GDC Data Portal Legacy Archive [30]. Instead of tumor tissues, genotype data from patients’ normal tissues
were used for all analyses to avoid miscalls from genotyping error and somatic mutations. The genotypes
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of the tag SNPs measured by Affymetrix human SNP array 6.0 were matched to hg19 coordinates using
Affymetrix genome-wide SNP annotation file. Tag SNPs with genotype confidence score > 0.01 were filtered
out. Untagged SNPs were imputed and phased from tagged SNPs of 513 LGG patients using the Michigan
Imputation Server [61]. We chose Haplotype Reference Consortium (HRC) panel [62] (version r1.1 2016)
which consists of 64940 haplotypes of predominantly European ancestry as the imputation reference panel
and Eagle2 [63] as the phasing engine. After the imputation, imputed SNPs were retained if the minor allele
frequency (MAF) exceeded 0.005 and estimated imputation accuracy (R2) exceeded 0.4. Then, imputed
genotypes were retained if the maximum of the estimated posterior probabilities for genotypes 0/0, 0/1 and
1/1 was larger than or equal to 0.9. Here, 0 denotes the SNP’s reference allele and 1 denotes the SNP’s
alternative allele. We thus could extract the imputed genotypes of all SNPs. We also extracted the haplotype
of SNPs using the imputed and phased results from the Michigan Imputation Server [61] (Section 2.2.4).
2.2.3 Expression quantitative trait loci (eQTL) linear model
Expression quantitative trait loci are genomic loci which explain the variation in the expression levels of
genes [64, 65]. eQTL analysis is widely used in the functional genomics field to identify the target gene whose
expression level, referred to as a quantitative trait, is associated with a single nucleotide polymorphism. In
our study, we performed expression quantitative trait loci analysis using the TCGA LGG data to identify
candidate target genes associated with the GWAS SNPs. We imputed high-confidence genotypes at the
GWAS SNPs and restricted the eQTL analysis to the genes residing within the 4Mb window centered at
each GWAS SNP. The choice of the 4Mb window was based on our underlying hypothesis that the SNPs
function by perturbing the interactions of enhancers and promoters. Enhancer-promoter interactions tend
to occur within the topologically associated domains (TADs), 92% of whose size lie between 200 and 2.5Mb
[66]. Thus, we chose 4Mb window centered around each GWAS SNP for the eQTL analysis. We used the
following multivariate linear regression model to assess the association between the GWAS SNP’s genotype
and the gene expression level, while adjusting for gene copy number, tumor site, tumor grade, histological
diagnosis, and gender:
Ei = αi + βi ·GT + γi · CNSi +
4∑
j=1
θijCovj + εi. (2.1)
In equation 2.1, i indexes the genes within the 4Mb window centered at the SNP; Ei = log2(RSEM + 1)
denotes the log-transformed gene expression level in RSEM unit; GT (genotype) ∈ {0, 1, 2} denotes the
number of alternative alleles of the GWAS SNP with respect to the human reference genome; CNSi is
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the length-weighted average of tumor copy number segmentation, log2(
copy number
2 ), covering gene i; Covj
represents each of the 4 covariates included in the eQTL analysis: tumor site, tumor grade, histological
diagnosis, and gender, where tumor site ∈ {“supratentorial, frontal lobe”, “supratentorial, occipital lobe”,
“supratentorial, parietal lobe”, “supratentorial, temporal lobe”, “supratentorial, not otherwise specified”},
tumor grade ∈ {“grade II”, “grade III”}, histological diagnosis ∈ {“astrocytoma”, “oligodendroglioma”,
“oligoastrocytoma”} and gender ∈ {“male”, “female”}; αi denotes the intercept; and, εi denotes the error
term.
2.2.4 Phased allele-specific expression (ASE) analysis
From the eQTL analysis, genes with false discovery rate (FDR) [67] adjusted pi ≤ 0.2, where pi is the P -value
of the genotype linear regression coefficient, were selected as candidate target genes. For each candidate
gene, we performed a phased allele-specific expression (ASE) analysis to test the differential transcription
between the two chromosomes harboring different alleles of a given GWAS SNP [68] (Figure 2.4). We first
obtained a subset of patients having heterozygous genotypes both at the GWAS SNP and at exonic SNPs of
the candidate gene. We then extracted the imputed haplotype from the imputation results (Section 2.2.2)
to determine the phase between the GWAS SNP and the exonic SNPs. Allele-specific coverage of the exonic
SNPs by RNA-Seq reads (MAPQ ≥ 20) was obtained using the code from Zhang et al. [68] and Wilcoxon
signed-rank sum test (for sample size n ≥ 5) was used to examine the transcription imbalance between the
two copies of chromosomes at a P -value threshold of 0.05.
2.3 TF prioritization
We have thus identified putative causal SNPs that reside in accessible regulatory chromatin regions (Section
2.1) and a set of putative target genes (Section 2.2). To verify our central hypothesis that the causal SNPs
modulate the expression of target genes through perturbing the binding affinity of transcription factors (TFs),
we further performed a series of analyses to prioritize candidate TFs. We first performed motif analyses to
select a set of TFs whose DNA binding affinity were significantly perturbed by the single nucleotide change
of candidate causal SNPs [68] (Section 2.3.1). We further filtered candidate TFs based on TF-target gene
correlation analysis (Section 2.3.2). To assess the impact of causal SNPs on candidate TFs, we at last trained
a convolutional neural network model on TF ChIP-seq data to predict allele-specific TF binding (Section
2.3.3) and deployed a simulated annealing method [69, 70] to extract the optimal TF motif learned by the
CNN (Section 2.3.4). The TF motif analyses (Section 2.3.1) were developed by Dr. Yi Zhang and Dr.
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Figure 2.4: Transcription imbalance from two copies of chromosomes could be revealed by phased ASE
analysis. Illustrative plots of 3 patients are shown in the figure. Heterozygous GWAS SNP and exonic SNP
are shown as small black bars in the figure. “0” denotes exonic SNP’s allele that in the same chromosome
(in phase) with the GWAS reference allele; “1” denotes exonic SNP’s allele that in the same chromosome
(in phase) with the GWAS alternative allele. Transcription imbalance from two copies of chromosomes is
represented by the amount of mRNA transcripts; “0” or “1” in mRNA represents the chromosome from
which the transcripts are transcribed. Through RNA-Seq, phased allele-specific coverage of the exonic SNP
could be obtained, and transcription imbalance could then be assessed for a pool of patients (samples) using
Wilcoxon signed-rank sum test (for sample size n ≥ 5).
Mohith Manjunath [68]. I will rephrase the methods briefly in Section 2.3.1 and Appendix A.2. Dr. Mohith
Manjunath also performed the ATAC-seq allele-specific read coverage analysis described in Section 2.3.3.
2.3.1 Motif analyses
We utilized motif scan software Find Individual Motif Occurrences (FIMO) [71] and 4 transcription factor
motif databases JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74], Jolma2013 [75] to select TFs whose
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motifs matched the flanking sequences covering causal SNPs [68]. FIMO computes the score for the match
of a position in a sequence to a motif given a position-specific scoring matrix (PSSM) which represents the
motif, and converts this score to a P -value, which is defined as the probability of a random subsequence of
the length of the motif scoring better than or as well as the original match [71]. We scanned ± 25bp flanking
sequences around putative causal SNPs (total length 51bp), and used P -value 10−3, 10−4 as FIMO output
thresholds to select a set of candidate TFs for downstream motif analysis [68].
We then performed motif permutation test using the output from FIMO [68]. The motif permutation
test aims to assess the significance of the motif disruption by the causal SNP through simulating neutral
mutations of the motif-matching sequence [68]. The details of motif permutation test are rephrased in
Appendix A.2. Setting permutation test P -value threshold as 0.05, we thus selected all TFs whose binding
affinity were significantly perturbed by the SNP.
2.3.2 TF-target gene correlation analysis
We then performed TF-target gene correlation analysis to further prioritize candidate TFs obtained from
the motif analyses. We started with a set of target genes from eQTL analysis and a set of TFs from the
motif analyses. We calculated Pearson correlation coefficients and Spearman correlation coefficients between
the target genes’ and TFs’ expression values (log transformed RSEM values, log2(RSEM + 1)) stratified into
three genotype groups (homozygous risk, heterozygous, homozygous non-risk). We performed the TF-target
gene correlation analysis both in LGG subgroups (“IDH mut only”, “triple-positive”) and in the combined
groups (all 5 molecular groups combined, “IDH mut only” and “triple-positive” combined). We then selected
the TFs based on the reasoning that the correlation or anti-correlation would likely be strongest in the
homozygous genotype group creating the TF binding motif, while the correlation would likely be weakest in
the homozygous genotype group disrupting the TF binding motif.
2.3.3 Allele-specific TF binding prediction using convolutional neural network
Based on the motif analyses and TF-target gene correlation analysis, we selected a set of candidate TFs
satisfying the following criteria: 1. the binding affinity of the TF was significantly perturbed by the candidate
causal SNP (motif permutation test P -value < 0.05); 2. the TF-target gene correlation stratified into three
genotype groups (denoted as AA, AB, BB) satisfied one of the following conditions in Table 2.1.
We further conducted two additional steps to identify the best candidate TF(s) out of the selected
ones. First, we tried to infer the chromosomal accessibility difference caused by the SNP through ATAC-seq









EAA > EAB > EBB A rAA > rAB > rBB ,
rAA > 0 and strongest
Activator
EAA > EAB > EBB B rAA > rAB > rBB ,
rBB < 0 and strongest
Repressor
EAA < EAB < EBB A rAA < rAB < rBB ,
rAA < 0 and strongest
Repressor
EAA < EAB < EBB B rAA < rAB < rBB ,
rBB > 0 and strongest
Activator
Table 2.1: A summary table of target gene expression, allele harbored by the binding motif, TF-target gene
correlation coefficient and the role of TF.
heterozygous TCGA-LGG samples at the causal SNP using bcftools mpileup [76] option. We considered
only the bases with a Phred quality score ≥ 20. For each sample, the significance of the skew between the
two alleles was evaluated using a binomial test. The resulted P -values were combined using the Fisher’s
method. If a significant skew toward the risk allele was observed, the risk allele might function by creating a
TF binding motif; whereas if a significant skew toward the non-risk allele was observed, the risk allele might
function by disrupting a binding motif, and the non-risk allele might function by preserving a binding motif.
Second, we examined candidate TFs’ all available ChIP-seq datasets from public databases, and performed
ChIP-seq allele-specific read counts analysis. We checked if the causal SNP resided in the peaks of the TF
ChIP-seq signal; we also examined if there was a significant skew between the read counts of the two alleles
in heterozygous cell lines [68]. The significance of a skew was measured by a binomial test, and one-sided
P -value was reported.
However, very few TF ChIP-seq datasets were available for brain-related cell types in public databases
such as Encyclopedia of DNA Elements [17] (ENCODE). Therefore, we could not verify the allele-specific
binding of some candidate TFs in brain cell types. Thus, for the candidate TF SP1 in rs12803321 locus
(Chapter 4), we trained a convolutional neural network (CNN) model on DNase-seq data and TF ChIP-seq
data of available cell types from ENCODE, and used the model to predict the allele-specific binding pattern
of the same TF in the human fetal brain.
We trained the CNN using the Keras package [77] and engineered several layers using TensorFlow [78].
The structure of the constructed CNN is shown in Figure 2.5. Each input sample consisted of a 1001 × 9
matrix containing the one-hot encoded forward and reverse DNA sequence information and the quantile-
normalized DNase-seq signal in the given 1001bp region. The CNN model had one convolutional layer
consisting of 40 convolutional filters. All convolutional filters had a size of 12×5 and slid on a 1001×5 input
matrix representing positive strand DNA sequence and DNase-seq signal. To capture the motifs present in
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Figure 2.5: CNN for predicting the binding pattern of transcription factor SP1 based on DNA sequence and
open chromatin information. From left to right: 1001bp×9 input matrix incorporating sequence information
and quantile-normalized DNase-seq signal at each base; convolutional layer using filters of length 12bp;
maximum layer, extracting the maximum of the convolutional layer output from the positive and negative
strands; maximum pooling layer; flatten and concatenate layer; fully connected layer with 80 neurons; fully
connected layer with 10 neurons; output.
negative strands, the 1001× 5 submatrix representing the corresponding reverse complement DNA sequence
and DNase-seq signal was passed through the same set of convolutional filters. We then extracted the
maximum of the convolutional layer output from the positive and negative strands, and passed the output
through a max pooling layer of size 40 and stride 40. The max pooling layer output was flattened and passed
to a fully connected layer of 80 neurons, and then was passed through a fully connected layer of 10 neurons.
Finally, the output of the second fully connected layer was passed to a single output neuron encoding the
27
binding probability of the TF. Rectified linear unit (ReLU) function was used as the activation function
throughout the CNN, except for the output layer where we utilized a sigmoid function to restrict the output






[−tilog(σi)− (1− ti)log(1− σi)], (2.2)
where N is the batch size; ti ∈ {0, 1} represents whether the TF truly binds the DNA or not, based on the
ChIP-seq experiment result; and σi is the output of the sigmoid function from the last layer. The CNN was
trained using Adam optimizer [31] with batch size 1000, and the training was stopped when the validation
loss did not decrease for over 100 epochs.
2.3.4 CNN learned motif extraction using a simulated annealing method
We used simulated annealing technique [69, 70], a Markov Chain Monte Carlo sampling method, to perform
probabilistic optimization of the CNN-learned motif over the set of input sequences. We extracted and
visualized the learned motif both for the CNN model (Section 4.3) and the tensor net model (Section 6.3)
of TF SP1.
The simulated annealing algorithm samples sequences through a discrete-time inhomogeneous Markov
chain with transition probabilities determined by a cost function J and a temperature parameter T . Specif-
ically, sequences with lower J values are sampled with higher probability, and as the temperature decreases,
the ratio of the sampling probability for sequences with lower J values to the sampling probability for
sequences with higher J values increases.
To sample sequence x that maximizes the input of the sigmoid function in the last layer of the trained
CNN, we used the cost function J(x) = −y(x), where y(x) denotes the pre-activation of the output neuron.
For the trained CNN, we initialized 50 instances of simulated annealing at the 50 elements of the test set
(in the CNN model of SP1, the test set was SP1 A549 chr1 ChIP-seq dataset) predicted to have the highest
pre-activation. The pseudocode for the simulated algorithm is given as Algorithm 1; x(n−1) is the input
sequence at the nth iteration, d is the initial temperature, and Niter − 2, Nsample, Ninterval are the iteration
total number, sample size and interval size, respectively. At each iteration, we only changed one nucleotide
in the sequence, while the quantile-normalized DNase-seq signal was held unchanged.
The initial temperature d is chosen by empirical observation of the distribution of the cost function J ,
in particular, by considering the height of communication of local minima [69]. Although we could not
guarantee obtaining global minima at the end of the simulation, we still wanted to make sure that the
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Algorithm 1 Simulated Annealing
1: Given: x0, J(x), d, Niter, Nsample, Ninterval
2: for n in (1, 2, . . . , Niter − 2) do
3: T = d/ log(n+ 1)
4: i ∼ Unif({0, . . . , 1001}) . select one base index in the input sequence
5: xproposed ≡ xn−1
6: (xproposed)i ∼ Unif({A,C,G,T} − {(xn−1)i}) . replace the nucleotide with a randomly sampled one
7: u ∼ Unif([0, 1])
8: if exp(− (J(xproposed)−J(xn−1)T ) > u then
9: xn = xproposed . Accept
10: else
11: xn = xn−1 . Reject
12: end if
13: return: {xn : (n > Niter − (Nsample)(Ninterval)− 2) and ((n+ 1) mod Ninterval = 0)}
14: end for
Markov chains could transition from shallow to deeper basins of the cost function J . We therefore selected
the initial temperature d by estimating the minimum communication height for sequences near the local
minima of the cost function. First, we supplemented each of the 50 test set inputs (A549 chr1) predicted
to have the highest pre-activation y(x) with 1000 inputs sampled uniformly and without replacement from
the union of training, validation, and test sets. To remove the variation in J(x) caused by DNase-seq,
we fixed the DNase-seq signal of all 1000 samples to the corresponding maximum pre-activation test input
DNase-seq signal. Next, for each of the test inputs and the supplemented 1000 samples, we calculated the
difference (Jm,k −min
j
(Jm,j)), where 1 ≤ k ≤ 1001, 1 ≤ m ≤ 50, and Jm,k denotes the kth value of J among
the 1001 samples associated with the test set input m. We then combined the calculated difference values,
and ranked these 50000 difference values. We observed a transition from a rapid increase to a moderate
increase for the 50000 ranked difference values. We thus estimated the fraction of inputs near strong local
minima and chose the 1st percentile of the ranked U50m=1{(Jm,k −min
j
(Jm,j)) : 1 ≤ k ≤ 1001} as a threshold,
yielding the threshold d as the initial temperature. The values of the other parameters were Niter = 5×105,
Nsample = 10
4 and Ninterval = 10. Using these parameters, we performed simulated annealing starting
from each of the 50 test inputs which were predicted to have the highest pre-activation values. For each of
the 50 simulated annealing experiments, we monitored the minimum of J(x) across the previous iterations
versus the iteration number n. After the minimum of J(x) stabilized, we recorded the sampled sequences
xn every 10 iterations starting from the 399999
th iteration for each simulated annealing experiment. For
the CNN model of SP1 in Section 4.3, we chose the experiment with the lowest stable min(J(x)) out of the
50 experiments as our best scenario, and visualized the CNN-learned motif using the recorded sequences
through WebLogo [79] 3.
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2.4 Experimental validation
Up till now, we have identified candidate causal SNPs (Section 2.1), target genes (Section 2.2) and tran-
scription factors (Section 2.3). For the best candidate (causal SNP, target gene, TF) triplets, we could then
perform in vitro and in vivo experiments to validate the computational analysis.
Electrophoretic mobility shift assay (EMSA)
For the GWAS locus harboring rs648044, we performed an electrophoretic mobility shift assay (EMSA)
experiment to confirm that the transcription factor MAFF preferentially binds rs648044-A allele. EMSA
is also known as gel shift assay, and is a common technique to determine if a protein or a mixture of
proteins could bind to a DNA or RNA sequence. In our experiment, we took positive control sequence,
negative control sequence, 81bp flanking sequence containing rs648044 risk allele A, 81bp flanking sequence
containing rs648044 non-risk allele G as inputs, and revealed the binding of MafF on positive control sequence
and the flanking sequence containing rs648044 risk allele A (Section 3.3, Appendix B.2 and B.3).
RNA interference (RNAi) experiment
We also performed an in vivo RNA interference (RNAi) experiment to assess the effect of MAFF mRNA
knockdown on target gene expression. RNAi is a gene-silencing process with exogenous or endogenous double-
stranded RNA (dsRNA) involved. For RNAi initiated by exogenous dsRNA, the ribonuclease protein Dicer
[80] binds and cleaves short hairpin RNAs (shRNAs), resulting in short double-stranded fragments [81, 82,
83, 84] - small interfering RNAs (siRNAs), which are then divided into single strand RNAs. The guide strand
is then integrated into an RNA-induced silencing complex (RISC). For post-transcriptional gene silencing,
the guide strand RNA in RISC pairs with a complementary sequence in the targeted mRNA, which is
subsequently cleaved by a catalyst in RISC [85]. In the experiment of our study, shRNA was transferred
into cells of a human IDH1R132H mutant, TERT promoter-mutant, 1p/19q-codeleted oligodendroglioma cell
line heterozygous at rs648044, and the expression level of putative target genes ZBTB16 and NCAM1 upon
MAFF knockdown was measured (Section 3.3, Appendix B.4).
Proposed experiment - Allele specific chromatin immunoprecipitation coupled with
quantitative PCR (ChIP-qPCR)
Besides EMSA and RNA interference experiments, here we also propose allele specific chromatin immuno-
precipitation coupled with quantitative PCR (ChIP-qPCR) experiment to validate the allele specific binding
of the candidate TFs [86, 87, 88]. ChIP-qPCR is a technique that could be used to indicate the interaction
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of transcription factors and genomic binding sites [89]. The DNA sequences in ChIP-qPCR experiment rely
on the primers to amplify. Allele specific ChIP-qPCR could further reveal the different enrichment level
of two alleles of a SNP by designing the “allele-specific mismatch amplification mutation assays primers”
[86, 90]. We thus could design two primers for two DNA sequences containing the risk and non-risk allele,
and quantitatively measure the enrichment level of two alleles. We could further perform high-throughput
sequencing to assess the allele-specific read coverage of the binding sites, which could help to validate the
allele binding preference of TFs [87].
31
Chapter 3
The functional role of 11q23.2 variant
rs648044 - ZBTB16 locus
The work done in this chapter has been published in Manjunath†, Yan† 1 et al., Neuro-oncology, 2020 [51].
The computational part of this chapter was performed by the author in collaboration with Dr. Mohith
Manjunath, who performed the ATAC-seq allele specific read counts analysis (in Section 3.2, Appendix
B.1), CIC mutation analysis (in Section 3.3, Appendix B.6). Dr. Mohith Manjunath also contributed
to PLAC-seq analysis (in Section 3.1), MAFF motif permutation analysis (in Section 3.2), and proposed
the potential interaction of ZBTB16 with CIC through analyzing the ChIP-seq data of ZBTB16 (Section
3.4). The EMSA experiment was performed by Yeoan Youn in Professor Paul R. Selvin’s lab at UIUC (in
Section 3.3, Appendix B.2), and the RNAi experiment was performed by Dr. Kristen L. Drucker in Professor
Robert B. Jenkins’ lab at Mayo Clinic (in Section 3.3, Appendix B.4, B.5). The positive and negative control
sequences in the experiments were provided by the author (Appendix B.3).
3.1 The lead SNP rs648044 modulates the expression of
ZBTB16 through chromatin looping
The lead GWAS SNP rs648044 contained no other SNP in high LD within its haplotype block (Figure 3.1)
and was thus our candidate causal variant. As functional variants often interact with their target genes
through active regulatory elements, we examined the epigenetic landscape surrounding the SNP in brain-
related tissues and cell lines. Independent ATAC-seq [54, 55] and DNase-seq datasets confirmed the SNP
to be located within an open chromatin region in TCGA LGG samples, oligodendrocytes and fetal brain
tissue samples (Figure 3.2A). Histone H3 lysine 4 mono-methylation (H3K4me1) and H3K27 acetylation
(H3K27ac) ChIP-seq in fetal brain and dorsolateral prefrontal cortex tissues showed an active enhancer
activity at the location (Figure 3.2A), as also annotated by REMC (Figure 3.3A).
We further identified the target gene as described below. The eQTL analysis using the genotypes and
gene expression data of TCGA LGG samples suggested NCAM1 and ZBTB16 to be the top candidate target
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Proxies for rs648044 in EUR
Chromosome 11 Coordinate (Mb)(GRCh37)
Figure 3.1: The lead GWAS SNP rs648044 contained no other SNP in high LD within its haplotype block.
The figure was downloaded from LDlink [58] with rs648044 as the query variant and European (EUR) as the
query population. R2 of each SNP and the combined recombination rate are shown in the figure. Purple,
yellow and red circles denote query variant, non-coding variants and coding variants, respectively. The
numbers (ranging from 1 to 7, from RegulomeDB [91]) in the circles represent the regulatory potential of the
variants, with 1 denoting the highest and 7 the lowest; the variant’s regulatory potential from RegulomeDB
is unknown if there is no number in the circle.
genes (Figure 3.2B, Figure 3.3B, NCAM1 P = 0.0054 in the combined “IDH mut only” and triple-positive
group). NCAM1 is located about 1.1 Mb away from ZBTB16. H3K4me3 PLAC-seq confirmed a physical
looping interaction only between the active ZBTB16 promoter and the enhancer harboring rs648044 in
oligodendrocytes [55] (Figure 3.4A). We thus prioritized ZBTB16 for further analysis. Correlation analysis
between ZBTB16 normalized expression values and genotype status at rs648044 in different molecular groups
found a significant association in the combined group of “IDH mut only” and triple-positive (P = 0.0118,
FDR = 0.124; Figure 3.3B). The expression level of ZBTB16 was suppressed by the rs648044-A risk allele,
indicating that ZBTB16 might act as a tumor suppressor. Consistent with this hypothesis, ZBTB16 encodes
a zinc-finger TF [92] implicated in inhibiting proliferation, metastasis or epithelial-mesenchymal transition
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Basic Gene Annotation Set from GENCODE Version 19
Figure 3.2: ZBTB16 intronic enhancer harboring rs648044 modulates mRNA expression of nearby genes.
(A) A snapshot of the ZBTB16 locus where the GWAS SNP rs648044 is denoted by a blue vertical line.
The shown epigenomic tracks are: TCGA-LGG ATAC-seq [54], oligodendrocytes ATAC-seq [55], and REMC
data in fetal brain and prefrontal cortex. (B) A zoomed-out view of the ZBTB16 locus encompassing the
eQTL target genes, NCAM1 and ZBTB16, indicated by red boxes.
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Figure 3.3: The GWAS SNP rs648044, located in an intron of ZBTB16, modulates ZBTB16 mRNA ex-
pression. (A) ChromHMM [53] tracks of 10 brain tissue samples from Roadmap Epigenomics Mapping
Consortium (REMC) database [28, 29] for the region harboring the GWAS SNP rs648044. The samples are
Brain Angular Gyrus, Anterior Caudate, Cingulate Gyrus, Germinal Matrix, Hippocampus Middle, Inferior
Temporal Lobe, Dorsolateral Prefrontal Cortex, Substantia Nigra, Fetal Brain Female and Fetal Brain Male.
(B) eQTL result for rs648044 and ZBTB16 in the combined TCGA-LGG “IDH mut only” and triple-positive
(TP) group. Throughout the text, the risk and non-risk alleles of a SNP are colored orange and blue,
respectively.
3.2 rs648044 likely perturbs the binding affinity of MAFF
We next sought to identify the TF whose binding affinity might be perturbed by rs648044. We first utilized
known TF binding motifs to perform in-silico TF binding affinity perturbation analysis based on a sequence
permutation test (Section 2.3.1, Appendix A.2). For each candidate TF, we then computed molecular
group-wise Pearson correlation coefficient between the TF and ZBTB16 expression levels stratified into
three genotype groups of rs648044 (Section 2.3.2). Based on the eQTL finding that ZBTB16 expression was
lower in the risk group (AA genotype), we expected a candidate repressor TF to have higher binding affinity
towards the risk allele A and show a greater negative correlation with ZBTB16 in the risk group compared
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to the GG genotype group; conversely, we expected a candidate activator TF to have lower binding affinity
towards the risk allele and show a weaker positive correlation with ZBTB16 in the risk group. ATAC-
seq data in TCGA LGG samples showed a significant skew toward the rs648044-A risk allele, indicating
that the TF might act as a repressor (P = 0.010, Fisher’s method for combining binomial test P -values;
Table B.1; Section 2.3.3, Appendix B.1). These criteria together identified MAFF as the top candidate TF
for further experimental validation. MAFF is a member of the small MAF basic leucine zipper TFs that
can homodimerize and repress target genes. Its motif [97] clearly preferred the risk allele A (Figure 3.4B;
permutation test P = 0.0029, Section 2.3.1, Appendix A.2), and the structure of expression correlation
showed attenuation of the negative correlation between MAFF and ZBTB16 in the AG and GG genotypes











LD  1     2  3 4 5 6 7 8
Ladder
               Positive C
ontorl + M
afF
                 rs648044-A



















































































113,950,000 114,000,000 114,050,000 114,100,000 114,150,000
Oligodendrocyte PLAC-seq (top interaction)
Gene 
Track
Figure 3.4: The GWAS SNP rs648044 likely perturbs the binding affinity of MAFF that represses ZBTB16.
(A) Oligodendrocyte PLAC-seq track [55] showing the rs648044 locus (blue vertical line) interacting with
the ZBTB16 promoter, about 100 kb away. (B) JASPAR [97] motif logo of the predicted TF MAFF and
two variants of the flanking sequence harboring rs648044-A and rs648044-G alleles. Throughout the text,
the risk and non-risk alleles of a SNP are colored orange and blue, respectively. (C) Pearson’s correlation
coefficient between ZBTB16 and MAFF in the combined “IDH mut only” and TP group, “IDH mut only”
subgroup and TP subgroup. (D) Gel picture from the EMSA experiment showing a ladder (“LD”) and eight
lanes using the mixture of the recombinant MafF protein and 4 different DNA sequences (Appendix B.2,
Appendix B.3): 81bp positive control (“PC”) sequence, 81bp sequence flanking rs648044-A, 81bp sequence
flanking rs648044-G and negative control (“NC”) sequence. The lower molecular weight bands in black
box correspond to free DNA. Orange box highlights the bands of MafF-bound DNA, corresponding to
the results of “positive control DNA + MafF” and “rs648044-A flanking sequence + MafF”. (E) MAFF
RNAi knockdown experiment results, showing a significant increase in ZBTB16 mRNA expression after
MAFF knockdown. One-sided t-test P -value between the control group and the combined group of three
independent shRNA clones is shown on the top.
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3.3 RNA interference and EMSA experiments
To confirm that MAFF preferentially binds the rs648044-A allele, we performed an electrophoretic mobility
shift assay (EMSA) (Figure 3.4D, Appendix B.2). We detected binding of MAFF on positive control DNA
(from a top consensus ChIP-seq peak region in HepG2, K562 and HelaS3, Appendix B.3; lane 2) and
the sequence containing the risk A allele (Appendix B.2; lane 4), but not on the sequence containing the
alternative G allele (Appendix B.2; lane 6) and negative control DNA (a permuted sequence with no MAFF
core binding motif, Appendix B.3; lane 8). Knockdown of MAFF using shRNA in a cell line – derived
from an IDH1R132H mutant, TERT promoter-mutant, 1p/19q-codeleted (triple positive) oligodendroglioma
patient and heterozygous at rs648044 (Appendix B.4) – led to a significant increase in ZBTB16 mRNA
expression compared to non-target controls (Figure 3.4E; P = 0.0294, two-group one-sided t-test), but not
in NCAM1 mRNA expression (Figure B.1; P = 0.37, two-group one-sided t-test). These results support
our prediction that MAFF preferentially binds the risk allele rs648044-A and represses the putative tumor
suppressor ZBTB16. We further analyzed the prevalence of CIC mutations in the context of rs648044
genotypes (Appendix B.6), as CIC is an important tumor suppressor frequently mutated in IDH mut gliomas.
CIC inactivating mutations tended to occur more frequently in the homozygous non-risk GG genotype than
the combined AA and AG genotypes in TCGA triple-positive gliomas (Odds ratio 2.0, Fisher’s exact test
P = 0.076; Table 3.1), although statistical significance could not be reached, potentially due to small sample
size. This finding suggested that the predicted suppression of ZBTB16 by the risk rs648044-A allele could
be an alternate mechanism for LGG tumorigenesis in CIC wild-type gliomas.
CIC status GG AA+AG
Mutant 16 25
Wildtype 15 48
Table 3.1: Inactivating mutation status of CIC in the triple-positive group stratified into non-risk (GG) and
risk (AA+AG) genotypes of rs648044.
3.4 ZBTB16 and CIC
We have shown that the 11q23.2 GWAS SNP rs648044 may modulate the expression of ZBTB16 by per-
turbing the binding affinity of MAFF. Although ENCODE ChIP-seq data show a MAFF peak (q-value
= 3.1×10−4) covering the SNP rs648044 in K562 cells, as well as a similar MAFK peak (q-value = 1.6×10−4)
in HepG2 cells, further studies are needed to confirm the allele-specific binding of MAFF at rs648044 in glioma
cells, as predicted by our computational analysis and in vitro data. ZBTB16 has been shown to regulate
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self-renewal and differentiation of hematopoietic stem cells, mainly acting as a transcriptional activator and
antagonized by a noncanonical function of the histone methyltransferase EZH2 [98]. It also acts as a tumor
suppressor in prostate cancer, melanoma, gallbladder cancer and leukemia [95, 96, 99, 100]. Although no
ZBTB16 ChIP-seq data are currently available in oligodendrocytes, ChIP-seq data in human mesenchymal
stem cells [101], endometrial stromal cells [102] and acute myelogenous leukemia cells [98] show ZBTB16
binding the CIC promoter in these cell types (Figure 3.5, Appendix B.7). The mRNA expression level of
ZBTB16 is also highly correlated with that of CIC in prefrontal cortex (Spearman’s ρ = 0.65, GTEx v8),
supporting that CIC is likely a direct transcriptional target of ZBTB16. Importantly, CIC is one of the
most commonly mutated genes in IDH mut oligodendrogliomas and located on chromosome 19q, which is
often codeleted with chromosome 1p in oligodendrogliomas. These observations thus suggest a potentially
important interaction network involving the regulation of CIC by ZBTB16 and disruption of this interaction
by rs648044 in the tumorigenesis of LGG. The fact that CIC mutation shows a trend of being more frequent
in the homozygous non-risk GG genotype of rs648044, where the expression level of ZBTB16 is elevated, is
consistent with this potential interaction between the two tumor suppressors. However, the sample size of
patients in our study may be too small to understand the genetic interactions accurately; furthermore, some
patients having the non-risk GG genotype of rs648044 may have mutations in other genes or harbor other
risk SNPs, leading to alternate mechanisms of LGG pathogenesis [12, 59].
Figure 3.5: ZBTB16 binds the CIC promoter in multiple cell types. A snapshot at the CIC locus from the
Integrative Genomics Viewer [103] showing ZBTB16 ChIP-seq data in human acute myelogenous leukemia
cell line KG1 [98], mesenchymal stem cells [101] and endometrial stromal cells [102].
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3.5 Conclusion
We have thus presented the (MAFF, rs648044, ZBTB16 ) triplet that might contribute to the pathogenesis
of LGG. Through concrete computational analysis we proposed that MAFF preferentially binds rs648044
risk allele A and represses the expression of the putative tumor suppressor ZBTB16 (Figure 3.6). We
performed in vitro EMSA experiment which showed the binding preference of MAFF to rs648044-A allele.
We also performed in vivo RNAi experiment, and validated the increase of ZBTB16 expression upon MAFF
knockdown. We then analyzed the prevalence of CIC mutations with regard to rs648044 genotype, and
found that CIC showed a trend of being more frequently mutated in the non-risk rs648044 GG genotype
group where ZBTB16 expression level was elevated. Since ZBTB16 binds the promoter of CIC in three cell
types and CIC is an important tumor suppressor frequently mutated in oligodendrogliomas, the predicted






























Figure 3.6: Illustrative plot showing the GWAS SNP rs648044 modulates the expression of ZBTB16 through
chromatin looping and perturbing the binding affinity of MAFF. (A) MAFF preferentially binds rs648044
risk allele A, and acts as a transcription repressor to repress the expression of ZBTB16. (B) rs648044 non-risk
allele G weakens the binding affinity of MAFF, and as a result the expression level of ZBTB16 is elevated.
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Chapter 4
The functional analysis of 11q23.3
variant rs12803321 - PHLDB1 locus
In this chapter, we present the functional analysis of 11q23.3 GWAS variant rs12803321. The work in this
chapter was mainly done by the author, and has been published in Manjunath†, Yan† 1 et al., Neuro-oncology,
2020 [51].
4.1 eQTL and phased ASE analyses implicate PHLDB1 as a
candidate target gene
We next applied our computational framework to the locus containing rs12803321 (reference allele: G (risk),
alternative allele: C), one of the most significant LGG GWAS SNPs. The SNP rs12803321, located in
the first intron of Pleckstrin Homology Like Domain Family B Member 1 (PHLDB1 ) (Figure 4.1C), was
reported to be significantly associated with the “IDH mut only” subgroup [104, 105]. An eQTL analysis
of 71 genes within 4Mb of rs12803321 in “IDH mut only” subgroup (Section 2.2.3) identified PHLDB1 and
Trehalase (TREH ) as the top candidate target genes (PHLDB1 P = 2.5×10−9, FDR = 1.82×10−7; TREH
P = 8× 10−5, FDR = 2.84 × 10−3; Figure 4.1A,B). The number of risk alleles was anticorrelated with the
expression level of PHLDB1 and TREH adjusted for covariates (Section 2.2.3). Since TREH expression was
low (zero RSEM in 68 patients out of total 193), we prioritized PHLDB1 for further analysis. We analyzed
the allele-specific transcription pattern of PHLDB1 using TCGA RNA-Seq raw reads and the exonic SNPs’
phased haplotype information (Section 2.2.4). There were 20 exonic SNPs with more than 5 cases in the
“IDH mut only” group having a heterozygous genotype at both rs12803321 and the exonic SNP. Wilcoxon
signed-rank sum test on the RNA-Seq read counts from the two chromosomes [68] detected a statistically
significant skew at 9 exonic SNPs out of 20 (P < 0.05). All these 9 SNPs showed higher transcription
emanating from the rs12803321-C haplotype (Figure C.1). These results together demonstrated that the
risk allele rs12803321-G was associated with decreased expression of PHLDB1 in the “IDH mut only” group.
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Figure 4.1: eQTL analysis indicates PHLDB1 and TREH as the top candidate target genes. (A) eQTL
result for rs12803321 and PHLDB1 in the TCGA-LGG “IDH mut only” subgroup. (B) eQTL result for
rs12803321 and TREH in the TCGA-LGG “IDH mut only” subgroup. (C) Gene track showing the GWAS
SNP rs12803321 and candidate target genes, PHLDB1 and TREH. rs12803321 is denoted by a blue vertical
line.
4.2 Candidate causal SNP rs12225399 perturbs the binding
affinity of SP1/SP2
We next prioritized candidate functional SNPs using epigenomic data. There were three SNPs in high LD
with rs12803321 (Table C.1, Section 2.1.2): rs67307131 (r2 = 0.98), rs12225399 (r2 = 0.97) and rs7125115
(r2 = 0.90). The GWAS SNP and all three high LD SNPs were located in open chromatin and active enhancer
regions, as assessed by the fetal brain DNase-seq, TCGA LGG ATAC-seq [54], oligodendrocyte ATAC-
seq [55], and prefrontal cortex histone modification (H3K4me1, H3K27ac) ChIP-seq data (Figure 4.2A).
Motif analysis using FIMO [71] yielded candidate TFs whose binding affinity might be perturbed by any
of the above four SNPs (Appendix C.3, C.4, C.5, C.6). Further filtering the TF list through TF-target
gene expression correlation analysis (Section 2.3.2), we determined rs12225399 to be the best candidate
causal SNP, and SP1/SP2 the top candidate TFs: first, rs12225399 was located near a local peak center
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in TCGA LGG and oligodendrocyte ATAC-seq (Figure 4.2A,B); second, sequence perturbation analyses
demonstrated that the rs12225399-C allele, in phase with the rs12803321-C allele, created a high-scoring
SP1/SP2 binding motif, whereas the rs12225399-G allele significantly perturbed the motif (FIMO SP1
P = 4.25× 10−5, Figure 4.3A; FIMO SP2 P = 5.53× 10−5, Figure 4.3B; permutation test SP1 P = 0.015,
SP2 P = 0.0023; Section 2.3.1, Appendix A.2); third, Pearson correlation coefficient between SP2 and
PHLDB1 in “IDH mut only” group was highest in the rs12225399-CC genotype (r = 0.40) and decreased in
rs12225399-GC (r = 0.26) and rs12225399-GG genotypes (r = 0.23) (Figure 4.3C). The correlation between
SP1 and PHLDB1 did not show the same trend as SP2 and PHLDB1 (Figure 4.3D); however, since SP1
and SP2 recognize similar sequences (Figure 4.3A,B), we could not rule out SP1 as not being functional at
the SNP. The high LD SNP rs7125115 was not selected as a candidate causal SNP, because our analysis
did not yield a good candidate TF (Appendix C.3). These results together implied that the rs12225399-C
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Figure 4.2: The epigenomic landscape of the region harboring the GWAS SNP rs12803321. (A) A snapshot
of the PHLDB1 locus where the GWAS SNP rs12803321 is denoted by a blue vertical line. The top three
tracks are: basic gene annotation set from GENCODE version 19, LGG GWAS SNPs from GWAS catalog
[106] and SNPs in high LD with rs12803321 from the Single Nucleotide Polymorphism Database [107]
(dbSNP 151). The lower epigenomic tracks are: TCGA-LGG ATAC-seq [54], oligodendrocytes ATAC-seq
[55], oligodendrocytes H3K27ac [55] and REMC data in fetal brain and prefrontal cortex. (B) Enlarged
view of the epigenomic landscape of the region harboring the GWAS SNP rs12803321 and three high LD
SNPs. Tracks from top to bottom are the oligodendrocytes H3K27ac [55], oligodendrocytes ATAC-seq [55]
and TCGA-LGG ATAC-seq signals [54].
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Figure 4.3: The high LD SNP rs12225399 likely modulates PHLDB1 expression by perturbing the binding
affinity of SP1/SP2. (A) SP1 motif logo MA0079.3 (JASPAR [24]) and two variants of the flanking sequence
harboring rs12225399-C and rs12225399-G alleles. Allele C and G of rs12225399 are colored blue and
orange, respectively. (B) SP2 motif logo MA0516.1 (JASPAR [24]) and two versions of the flanking sequence
harboring the rs12225399-C and rs12225399-G alleles. (C) Scatter plots of SP2 vs. PHLDB1 expression
in the three genotypes of rs12225399 in the TCGA-LGG “IDH mutonly” subgroup. Spearman’s correlation
coefficients between SP2 and PHLDB1 in the “IDH mut only” group are: ρ = 0.25 (rs12225399-GG), ρ = 0.26
(rs12225399-GC), ρ = 0.36 (rs12225399-CC). (D) Scatter plots of SP1 vs. PHLDB1 expression in the three
genotypes of rs12225399 in the TCGA-LGG “IDH mut only” subgroup.
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4.3 SP1 allele-specific binding prediction using CNN
Because of the lack of SP1/SP2 ChIP-seq data in brain cell types, we could not verify directly whether
SP1/SP2 actually bound the predicted causal SNP. We thus applied a deep learning method to predict TF
binding affinity in fetal brain samples (Section 2.3.3). Although SP2 was a better candidate, SP2 ChIP-seq
data were available in only one ENCODE cell line, while SP1 ChIP-seq data were available in seven cell lines
(H1-hESC, HEK293T, HepG2, Liver, K562, MCF-7, and A549; Table C.10). We thus trained a CNN for
SP1 only, using sequence information and cell type-matched DNase-seq to predict the SP1 ChIP-seq signals.
4.3.1 Basic structure of constructed CNN and the training details
The structure of the constructed CNN is shown in Figure 2.5. The training details are stated below. We
trained the CNN using SP1 ChIP-seq data from six cell lines/tissue (H1-hESC, HEK293T, HepG2, Liver,
K562, MCF-7) and tested its performance using the cell line A549 (Table C.10). We obtained DNase-seq
and ChIP-seq data in the above cell lines from ENCODE or REMC databases, and performed quantile
normalization to reduce batch effect. We then collected all optimal ChIP-seq peak regions centered around
peak centers to form the positive dataset (102934 samples) and selected an equal number of regions with
no ChIP-seq peak to form the negative dataset. To increase the number of training samples and reduce
overfitting, we then translated our initial positive and negative datasets by -20 bp, -10 bp, 0 bp, 10 bp, and
20 bp to form the translated positive and negative datasets. After removing the samples that fell into hg19
“blacklist” regions, we obtained a total of 514668 samples for the translated positive dataset and 514634
samples for the translated negative dataset. Thus, our CNN model has total parameter number 80141 (2440
parameters, convolutional layer; 76880 parameters, first dense layer; 810 parameters, second dense layer; 11
parameters, third dense layer), and total sample number 1029302. We then split the translated datasets
into training and validation datasets with ratio 80% to 20% (training dataset: 823441 samples; validation
dataset: 205861 samples). We tested the performance of the trained CNN using A549 chromosome 1 (chr1)
positive and negative datasets (3785 samples for each) and calculated the receiver operating characteristic
(ROC) area under curve (AUC) (Figure 4.4A). Finally, the trained CNN was used to predict the binding
affinity of SP1 at rs12225399 using the REMC fetal brain DNase-seq samples as input (Table C.11).
4.3.2 Extraction of CNN-learned motif of SP1 using simulated annealing
We next extracted the CNN-learned motif of SP1 using the simulated annealing technique [69, 70]. Simulated
annealing is a Markov Chain Monte Carlo sampling method, and was applied by Dr. Alex Finnegan for the
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probabilistic optimization of CNN-predicted methylation rates over allowed input sequences [69]. Based on
Dr. Alex Finnegan’s method, we modified and used it to perform probabilistic optimization of the CNN-
learned motif of SP1 over the set of input sequences. The details of our simulated annealing method is stated
in Section 2.3.4. We summarize the basic steps and used parameters here.
We initiated 50 instances of simulated annealing at the 50 elements of A549 chr1 ChIP-seq test dataset
predicted to have the highest pre-activation. We followed the pseudocode listed in Algorithm 1 with the
following parameters: initial temperature d = 2.24; Niter = 5× 105; sample size Nsample = 104 and interval
size Ninterval = 10. For each of the 50 simulated annealing experiments, we monitored the minimum of
J(x), which is defined as J(x) = −y(x), where y(x) denotes the pre-activation of the output neuron, across
the previous iterations versus the iteration number n. After the minimum of J(x) stabilized, we recorded
the sampled sequences every 10 iterations starting from the 399999th iteration for each simulated annealing
experiment. We then chose the experiment with the lowest stable min(J(x)) out of the 50 experiments as
our best scenario, and visualized the CNN-learned motif using the recorded sequences through WebLogo [79]
3.
The optimal motif extracted from the simulated annealing method closely resembled the known SP1
motif [24] (Figure 4.4C, Figure 4.3A). We thus could use the trained CNN model for allele-specific binding
prediction at the two alleles of rs12225399 in the fetal brain.
4.3.3 The CNN model predicted differential binding of SP1
We first tested the performance of the trained CNN model using A549 chr1 positive and negative datasets
(3785 samples for each), and calculated the receiver operating characteristic (ROC) area under curve, re-
sulting in 0.95 (Figure 4.4A). Moreover, we confirmed that the optimal CNN-learned motif, extracted via a
simulated annealing method, closely resembled the known SP1 motif [24] (Figure 4.4C, Figure 4.3A). The
trained CNN was then used to evaluate the impact of rs12225399 on SP1 binding in the brain, taking the
allele information and quantile normalized DNase-seq profiles in 13 REMC fetal brain samples as input.
Our model predicted differential binding of SP1 at the two alleles of rs12225399, showing higher predicted
probability of binding at the C allele than the G allele across all 13 REMC samples (Figure 4.4B).
4.4 Discussion
We have proposed PHLDB1 to be a candidate target gene repressed in the risk genotype of rs12803321.




























































CNN learned motif using simulated annealing method
Figure 4.4: The CNN model predicted higher binding probability of SP1 at the rs12225399-C allele than the
rs12225399-G allele. (A) Receiver operating characteristic (ROC) curve assessing the performance of the
CNN model trained on six ENCODE SP1 ChIP-seq datasets (H1-hESC, HEK293T, HepG2, Liver, K562,
MCF-7). Test set was chr1 data in the A549 cell line. Area under the curve (AUC) = 0.95. (B) The difference
of SP1 binding probability between the two alleles of rs12225399, predicted by the CNN model based on 13
REMC fetal brain DNase-seq datasets from 10 donors. (C) CNN-learned motif visualized through a motif
logo obtained from WebLogo [79] 3. The core motif inside the red box resembles the core motif of SP1
MA0079.3 (Figure 4.3A).
study implicating PHLDB1 for a different GWAS SNP [27]. Knockdown of PHLDB1 has been shown to
increase cell death and reduce neurosphere formation in the U87MG glioma cell line [27], but its molecular
function remains poorly understood. We have developed a deep learning approach for predicting the binding
pattern of TFs when their ChIP-seq data are not available in the human brain. Most previous machine
learning approaches have been using only sequence information for predicting protein binding patterns [32],
and some recent studies have begun to utilize other genomic and epigenomic information [108]. Our deep
learning model integrates DNase-seq signal with sequence information into one convolutional filter. Using
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the convolutional neural network trained on non-brain cell data to evaluate sequence and open chromatin
information in brain tissues has allowed us to predict allelic preference of SP1 binding. A similar approach
may benefit future functional genomics studies in the brain, where TF ChIP-seq data are not readily available.
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Chapter 5
The functional role of 3q14.1 variant
rs11706832 - LRIG1 locus
In this chapter, we present the functional role of 3q14.1 GWAS variant rs11706832. The work in this chapter
has been published in Manjunath†, Yan† 1 et al., Neuro-oncology, 2020 [51]. The analysis in this chapter
was mainly done by the author.
5.1 eQTL and phased ASE analyses implicate SLC25A26 as a
candidate target gene
The LGG GWAS SNP rs11706832 (reference allele: A, alternative allele: C (risk)), located in an intron of
Leucine rich repeats and immunoglobulin like domains 1 (LRIG1 ) (Figure 5.1), was reported to be associated
with “IDH mut only” and triple-positive glioma subgroups [104]. Although highly expressed in the brain,
LRIG1 did not show a significant eQTL association with rs11706832 in TCGA LGG data (P = 0.52 and 0.34
for “IDH mutonly” and triple-positive, respectively), in agreement with a previous report [12]. By contrast,
we found that Solute carrier family 25 member 26 (SLC25A26 ), a gene 432kb away from LRIG1, was
significantly associated with rs11706832 in eQTL and phased ASE analyses: the number of rs11706832 risk
allele C was positively correlated with the expression level of SLC25A26 (Figure 5.2; genotype P = 2.9×10−3,
“IDH mut only”; 4.11 × 10−2, triple-positive; 2.11 × 10−4, “IDH mut only” and triple-positive combined;
FDR = 1.48 × 10−3, “IDH mut only” and triple-positive combined). Phased ASE analysis identified seven
exonic SNPs with a Wilcoxon signed-rank sum test P < 0.05 (“IDH mut only” and triple-positive combined
group, case number > 5). Five of these 7 exonic SNPs showed a significant transcriptional skew toward the
rs11706832-C allele (Figure 5.3), in agreement with the eQTL result, while the other two showed an opposite
trend. These results suggested that a functional consequence of the GWAS risk allele rs11706832-C was to
increase the expression of SLC25A26.
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Figure 5.1: The GWAS SNP rs11706832 resides in a regulatory element within an LRIG1 intron. A snapshot
of the LRIG1 locus where the GWAS SNP rs11706832 is denoted by a blue vertical line. The top three tracks
are: basic gene annotation set from GENCODE version 19, LGG GWAS SNPs from GWAS catalog [106]
and SNPs in high LD with rs11706832 (dbSNP [107] 151). The lower epigenomic tracks are: TCGA-LGG
ATAC-seq [54], oligodendrocytes ATAC-seq [55], oligodendrocytes H3K27ac [55] and REMC data in fetal
brain and prefrontal cortex.
5.2 Functional analysis of rs11706832 locus identifies the
(rs11706832, SLC25A26, LEF1) triplet
Of all three SNPs in high LD with rs11706832 (Table D.1), rs4402869 (r2 = 0.87) and the GWAS SNP
rs11706832 resided in open chromatin and active enhancer regions (Figure 5.1). Motif analysis and gene-
TF expression correlation analysis for rs11706832 and rs4402869 identified rs11706832-LEF1 to be the best
candidate SNP-TF pair (Appendix D.3, D.4), with the rs11706832-A allele potentially creating a LEF1
binding motif (FIMO P = 9.4 × 10−4, Figure D.1A) and the A-to-C conversion significantly perturbating
the binding motif (permutation test P = 0.012). The correlation structure between LEF1 and SLC25A26
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Figure 5.2: The GWAS SNP rs11706832 is associated with an increased expression of SLC25A26. (A) eQTL
result for rs11706832 and SLC25A26 in the combined TCGA-LGG “IDH mut only” and triple positive (TP)
group. (B) Similar to (A), but for the “IDH mut only” subgroup. (C) Similar to (A), but for the triple
positive (TP) subgroup.
was clearly strongest in the AA genotype when all LGG samples were used (Figure D.1B,C). These results
together suggested that the rs11706832-A allele might create a binding site of LEF1, a known transcriptional
repressor [109], thereby suppressing the expression of SLC25A26.
5.3 Discussion
From Section 5.1 and 5.2, we have shown SLC25A26 expression to be elevated in the risk group. It is
worth noting that this gene belongs to the mitochondrial carrier family and encodes a protein involved
in transporting S-adenosylmethionine into the mitochondria [110]. It has been shown that overexpression
of SLC25A26 in CaSki cells contributes to mitochondrial DNA (mtDNA) hypermethylation [111] and that
mtDNA methylation level tends to decrease during glioblastoma progression [112]. Future studies may reveal
how potential mtDNA methylation changes attributable to SLC25A26 modulation by rs11706832 contribute
to LGG tumorigenesis.
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 Opposite direction with eQTL
Figure 5.3: Phased allele-specific transcription pattern of SLC25A26 at 7 exonic SNPs in the combined
TCGA-LGG “IDH mut only” and triple-positive group. 5 of these 7 exonic SNPs show a significant tran-
scriptional skew toward the rs11706832-C allele (marked by magenta lines), in agreement with the eQTL
result, while the other two show an opposite trend (marked by brown lines). For each exonic SNP, RNA-Seq
read count differences between the two chromosomes harboring the rs11706832-A allele and the rs11706832-
C allele are sorted across patients and shown as bar plots. The P -value from the Wilcoxon signed-rank sum
test is shown at the top of each bar plot. The genomic locations of these 7 exonic SNPs are shown in the
GENCODE Version 19 track.
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Chapter 6
Neural network parameter reduction
using tensor train decomposition
In this chapter, we first review the related concepts of TT-decomposition and the idea of applying TT-
decomposition to neural network parameter reduction. We then demonstrate that the parameter-reduced
CNN of SP1 performs well. The analysis in this chapter was performed by the author. The results in this
chapter have not been published.
6.1 Tensor train decomposition (TT-decomposition)
Tensors can be viewed as multidimensional generalizations of vectors and matrices. Tensor is defined as a
d-dimensional array: A = A(i1, . . . , id), where A denotes a tensor and ik (k = 1, . . . , d; 1 6 ik 6 nk) denotes
the dimension index. In Chapter 1, we presented two ways for performing tensor decomposition: canonical
polyadic decomposition (CP decomposition) and higher-order singular value decomposition (HOSVD). Both
of them have certain disadvantages, which motivates us to study a new format of tensor decomposition,
called tensor train decomposition (TT-decomposition). We will explain the TT-format of a given tensor in
detail in this section.
6.1.1 TT-format
Suppose we approximate a given tensor B by a tensor A (A ≈ B), whose elements are expressed as [34]:
A(i1, . . . , id) = G1(i1)G2(i2) . . . Gd(id), (6.1)
where Gk(ik) is an rk−1× rk matrix [34]. We call the matrix product in equation 6.1 the tensor train format
(TT-format) of tensor A. Equation 6.1 can be interpreted as: one tensor element with index (i1, . . . , id) is
expressed by the product of d matrices, where the kth (1 6 k 6 d) matrix has dimension rk−1 × rk, with
r0 = 1 and rd = 1. Denoting nk as the number of all available values of ik, the above mentioned Gk(ik) is
actually a rk−1 × nk × rk three-dimensional array, with elements Gk(βk−1, ik, βk) = Gk(ik)βk−1βk . Now we
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can write equation 6.1 in the index form [34]:
A(i1, . . . , id) =
∑
β0...βd
G1(β0, i1, β1)G2(β1, i2, β2) . . . Gd(βd−1, id, βd). (6.2)
To better illustrate the tensor train format, we give an example in Figure 6.1. The tensor element A2132
is equal to the product of the 4 matrices marked by blue. Each core Gk (k ∈ [1, 2, 3, 4]) represents an
rk−1 × nk × rk three-dimensional array, where rk are the compression ranks or TT-ranks of the tensor train
decomposition, and nk is the dimension of ik. The TT-format uses O(ndr
2) memory to store nd elements
in the tensor, which is efficient when the TT-ranks are small.
× × ×𝐴!"#! = 
𝐺" 𝐺! 𝐺# 𝐺$
𝑖! = 2 𝑖" = 1 𝑖# = 3 𝑖$ = 2








Figure 6.1: An example of tensor train decomposition. The figure is modified from
https://t3f.readthedocs.io/en/latest/faq.html [113]. A2132 denotes one element in tensor A whose indexes
are: i1 = 2, i2 = 1, i3 = 3 and i4 = 2; Gk (k ∈ [1, 2, 3, 4]) denote the cores of TT-decomposition, and the
matrices whose product is equal to A2132 are marked by blue; rk denote the ranks of the TT-decomposition.
We could also express the tensor train format in the following graphical way [114, 115]. For example,
when d = 4, the graphical representation of TT-format is:
Figure 6.2: Graphical representation of the tensor train format, figure modified from I. V. Oseledets [34].
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There are two types of nodes in Figure 6.2: the rectangular node and the circle node [34]. Rectangular
nodes contain spatial indices ik and auxiliary indices βk [34]. Circles only have the auxiliary indices βk and
represent a link: we connect the two cores if an auxiliary index is present in these two cores [34]. Here, we also
assume the summation over the auxiliary indices, which corresponds to the summation in equation 6.2 [34].
The graphical representation looks like a train, which corresponds to the name “tensor train decomposition”.
It is worth to mention that this name was first proposed by I. V. Oseledets.
6.1.2 TT-SVD algorithm
We have presented the TT-format in Section 6.1.1. The question arises next is how to get the TT-format
either exactly or approximately for a tensor. Mathematically, we could describe the approximation question
as below: given a prescribed accuracy ε, how to approximate a given tensor A with Â in the TT-format
such that ‖A− Â‖F ≤ ε‖A‖F [34]?
I. V. Oseledets first proposed the TT-SVD algorithm to obtain the TT-format of a given tensor [34]. As
implicated by the name, TT-SVD algorithm computes the TT-decomposition through d sequential singular
value decompositions (SVDs) [34]. In this section, we will first give the definition of the unfolding matrix,
which is heavily used in the algorithm, then present the stepwise TT-SVD algorithm.
The unfolding matrix of tensor A is defined as:
Ak = Ak(i1, . . . , ik; ik+1, . . . , id) = A(i1, . . . , id), (6.3)
where the first k indices enumerate the rows of Ak, and the last d− k indices enumerate the columns of Ak
[34]. We can think this unfolding as: for a element of A indexed by (i1, . . . , id), its position in the unfolded






Suppose the unfolding matrix of a given tensor is of low rank only approximately, i.e., the unfoldings Ak
of the tensor A satisfy: Ak = Rk +Qk, where rank(Rk) = rk, ‖Qk‖F = εk (k = 1, . . . , d− 1) [34]. It can be





With the unfolding matrix defined and the above theorem stated, we then present the TT-SVD algorithm
below. The TT-SVD algorithm starts from the truncation parameter δ, which is equal to ε√
d−1‖A‖F , where
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ε is the given accuracy. The algorithm also involves reshaping the matrices and computing the δ-truncated
SVD iteratively.
Algorithm 2 TT-SVD algorithm, modified slightly from I. V. Oseledets [34].
1: Given: A d dimensional tensor A, accuracy ε.
2: Goal: Get the cores G1, . . . , Gd of the TT-approximation Â to A with TT-ranks r̂k of Â equal to the
δ-ranks of the unfoldings Ak of A, where δ =
ε√
d−1‖A‖F . Â satisfies ‖A− Â‖F ≤ ε‖A‖F .
3: Begin: Compute the truncation parameter δ = ε√
d−1‖A‖F . Set the temporary tensor as D, D = A.
r0 = 1.
4: for k in (1, 2, . . . , d− 1) do
5: D := reshape(D, [rk−1nk,
Thenumber of elements inD
rk−1nk
])
6: Compute δ-truncated SVD: D = USV T + E, ‖E‖F ≤ δ, rk = rankδ(D)
7: Get the kth core: Gk = reshape(U, [rk−1, nk, rk])
8: Set D = SV T
9: end for
10: Gd = D
11: Return: Tensor A’s approximation Â in the TT-format: G1G2 . . . Gd.
6.2 TT-decomposition applied to neural network compression -
tensor net
In a convolutional neural network, the fully connected layer transforms a high-dimensional input signal
(denoted by x) to a high-dimensional output signal (denoted by y) with a large dense matrix W and bias
vector b:
y = Wx+ b. (6.5)
The parameter number in the fully connected layer often consists of the largest portion of the total parameter
number in a convolutional neural network, as a result of which large training datasets are required and
overfitting could potentially occur. Therefore, numerous attempts have been made to reduce the parameter
number of the fully connected layer. For example, studies utilizing the low-rank approximation of the weight
matrix have been performed [116, 117, 40]. In line with the low-rank idea, A. Novikov et al. [40] proposed to
treat the weight matrix as a multi-dimensional tensor and employed TT-format [34] to represent the tensor.
One of the advantages of this method is that the back-propagation [118] derivatives can be computed using
the properties of the TT-format [34, 40]. Following the naming convention proposed by A. Novikov et al.
[40], we refer to the fully-connected layer in the TT-format as “TT-layer” and the neural network with
one or more TT-layers as “tensor net”. In the remaining part of this section, we first introduce the TT-
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representation of vectors and matrices [34, 40], then introduce the TT-format of the linear transformation
in a fully-connected layer [40], and at last present the learning process of the TT-layer embedded neural
network [40].
Consider a vector b with length N =
∏d
k=1 nk. We can always construct a bijection from l ∈ {1, 2, . . . , N}
to the d-dimensional index vector µ(l) = (µ1(l), µ2(l), . . . , µd(l)), where µk(l) ∈ {1, 2, . . . nk}. With the
bijection defined, we can write the vector in the form of a d-dimensional tensor B:
b(l) = B(µ1(l), µ2(l), . . . , µd(l)). (6.6)
Thus, the elements in vector b is stored in a tensor B. A vector in the TT-format is called a TT-vector [40].




k=1 nk, we can construct
the bijection from both row index t and column index l to vectors: τ (t) = (τ1(t), τ2(t), . . . , τd(t)), µ(l) =
(µ1(l), µ2(l), . . . , µd(l)), where τk(t) ∈ {1, . . . ,mk} and µk(l) ∈ {1, . . . , nk}. Thus, we store the matrix as a
d-dimensional tensor W, whose kth dimension is of length mknk, and is indexed by a long index (τk(t), µk(l))
[34, 40]:
W (t, l) = W (((τ1(t), µ1(l)), . . . , (τd(t), µd(l))). (6.7)
The TT-format of W with dimension M ×N is thus [40]:
W (t, l) = W (((τ1(t), µ1(l)), . . . , (τd(t), µd(l)))
= G1[τ1(t), µ1(l)] . . . Gd[τd(t), µd(l)]. (6.8)
The matrices Gk[τk(t), µk(l)] (k = 1, . . . , d) are the TT-cores with tuple (τk(t), µk(l)) being an index. A
matrix in the TT-format is called a TT-matrix [40].
Now we can write down the TT-format of the linear transformation y = Wx+ b (W ∈ RM×N , b ∈ RM )
in a fully connected layer as [40]:
Y (i1, . . . , id) =
∑
j1,...,jd
G1[i1, j1] . . . Gd[id, jd]X(j1, . . . , jd) +B(i1, . . . , id). (6.9)
In equation 6.9, the matrix is written in the TT-format, while the vector x is stored explicitly as a d-
dimentional tensor X, i.e., we do not decompose X into the product of TT-cores X1(j1) . . . Xd(jd). The com-
putational complexity for the TT-matrix-by-explicit-vector product z = Wx =
∑
j1,...,jd
G1[i1, j1]. . .Gd[id, jd]
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X(j1, . . . , jd) is O(dr
2mmax{M,N}) [40], where d is the number of the cores of the TT-matrix; r is the
maximum of ranks rk (k = 1, . . . , (d− 1)); m is the maximum of mk (k = 1, . . . , d); M =
∏d
k=1mk is equal
to the row number of the weight matrix W ; and N =
∏d
k=1 nk is equal to the column number of the weight
matrix W .
To update all the trainable parameters in the neural network learning process, we need to calculate the
gradient of the loss function L with regards to the parameters through the back-propagation procedure
[118]. Suppose x, y, W and b are the input vector, output vector, weight matrix and bias vector of the fully



















We are able to update the the bias vector b in the fully connected layer and the parameters in previous
layers using the derivatives given in equation 6.10, where ∂L∂x = W
T ∂L
∂y is calculated by the TT-matrix-by-
explicit-vector product [40]. In order to update the weight parameters, one way is to compute the gradient
of the loss function with regards to the weight matrix, then convert the gradient matrix into the TT-format
using the TT-SVD algorithm [34], and then add the gradient multiplied by a step size to the current weight
matrix: Witer+1 = Witer + γiter
∂L
∂W [40]. However, this approach requires O(MN) memory to compute
∂L
∂W
[40]. Thus, A. Novikov et al. proposed to compute the gradient of the loss function with regards to the cores
of the TT-matrix directly [40]. In order to make the notation clear, A. Novikov et al. used the compressed
notation for the indices before and after ik: i
−
k := (i1, . . . , ik−1), i
+
k := (ik+1, . . . , id), i = (i
−
k , ik, i
+
k ) [40],











k ] := Gk+1[ik+1, jk+1] . . . Gd[id, jd]. (6.11)
Equation 6.9 for k (k = 2, . . . , d− 1) was thus written as [40]:



















k , jk, j
+
k ) +B(i). (6.12)
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TX(j−k , j̃k, j
+
k ), (6.14)
one can utilize dynamic programming twice to compute [40]. The overall time complexity of the backward
pass is O(d2r4mmax{M,N}), and the memory usage of the backward pass is O(r3 max{M,N}) [40].
For our experiments of SP1 binding prediction to be presented in Section 6.3, we utilized the package
T3F, developed by A. Novikov et al. [113]. Since T3F uses TensorFlow as backend, we could incorporate
the TT-layer into our original CNN model (Section 4.3) easily.
6.3 Parameter reduction of SP1 binding predictive model using
tensor net
6.3.1 Motivation and the basic structure of the CNN-TT model
In Section 4.3, we presented a convolutional neural network model for TF SP1 binding prediction. There are
80141 parameters in the original CNN model, where the first fully connected layer consists of the majority
(95.9%) of the total parameter number (Table 6.1). Therefore, to avoid overfitting, we translated the
positive and negative datasets by -20bp, -10bp, 0bp, 10bp, 20bp, yielding 1029302 samples as the translated
dataset for training and validation. However, it is difficult to obtain such large ChIP-seq dataset (even
after translation) for other transcription factors. Moreover, it is a general trend to reduce the running time
and memory requirement in the deep learning field. Recent studies have shown that the fully connected
layer could be compressed without significant drop of the predictive power [116, 117, 119, 40]. We thus
applied TT-decomposition [34, 40] to the first fully connected layer of the original CNN model, and tested
its performance. We call the CNN model with the TT-layer embedded as the CNN-TT model in the following
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context, to differentiate from the original CNN model in Section 4.3.
Layer Number of parameters
Convolutional layer 2440
First dense layer 76880
Second dense layer 810
Third dense layer 11
Table 6.1: Parameter number of different layers in the original CNN model. First dense layer contains 95.9%
of all parameters.
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0     1    0     0    0    0     1    0   0.0
0     0    1     0    0    1     0    0   0.2
1     0    0     0    0    0     0    1   0.3
1     0    0     0    0    0     0    1   0.2
0     0    1     0    0    1     0    0   0.3
0     0    0     1    1    0     0    0   1.0
0     0    1     0    0    1     0    0   1.0
1     0    0     0    0    0     0    1   1.2
0     1    0     0    0    0     1    0   1.2
0     0    0     1    1    0     0    0   1.2
0     0    0     1    1    0     0    0   1.5
0     1    0     0    0    0     1    0   2.5
0     1    0     0    0    0     1    0   2.0
0     0    0     1    1    0     0    0   1.3
0     0    0     1    1    0     0    0   1.0
0     1    0     0    0    0     1    0   0.5
0     0    1     0    0    1     0    0   0.5
1     0    0     0    0    0     0    1   0.3
1     0    0     0    0    0     0    1   0.3
0     1    0     0    0    0     1    0   0.2
0     0    1     0    0    1     0    0   0.2
0     0    0     1    1    0     0    0   0.1
1     0    0     0    0    0     0    1   0.1
0     1    0     0    0    0     1    0   0.0
0.7
INPUT
Sequence (+) Sequence (-) DNase



































Figure 6.3: The basic structure of the TT-layer and the CNN-TT model. (A) The TT-format of the
linear transformation y = Wx+ b, where the weight matrix was decomposed into the product of TT-cores
G1G2 . . . Gd, and the input x, the output y, the bias b were stored as tensor X, Y, B. The TT-format of the
fully connected layer is thus: Y (i1, . . . , id) =
∑
j1,...,jd
G1[i1, j1] . . . Gd[id, jd]X(j1, . . . , jd)+B(i1, . . . , id). (B)
The structure of the CNN-TT model for predicting the binding pattern of SP1 based on DNA sequence and
open chromatin information. From left to right: 1001× 9 input matrix incorporating sequence information
and quantile-normalized DNase-seq signal at each base; convolutional layer using filters of length 12bp;
maximum layer, extracting the maximum of the convolutional layer output from the positive and negative
strands; maximum pooling layer; flatten and concatenate layer; TT-layer with input dimension 960 and
output dimension 80; fully connected layer with 10 neurons; output.
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The structure of the CNN-TT model is stated below. We substituted the first fully connected layer with
the TT-layer, where the weight matrix was decomposed as the product of TT-cores G1G2 . . . Gd, and the
input vector x, the output vector y, the bias vector b were transformed to tensor X, Y, B (Figure 6.3A). We
kept other layers of the original CNN model unchanged, yielding the full structure of the CNN-TT model
(Figure 6.3B). The training and validation dataset was the same with the dataset before translation for
the original CNN model: there were 102934 samples in the positive set and 102934 samples in the negative
set (from 6 cell types: H1-hESC, HEK293T, HepG2, Liver, K562, MCF-7; Section 4.3.1), yielding 205868
samples in total. We then split the 205868 samples into training and validation datasets with ratio 80%
to 20% (training dataset: 164694 samples, validation dataset: 41174 samples). We trained the CNN-TT
model using T3F library t3f.nn.KerasDense function [113], with different ranks of the TT-cores (Table 6.2).
For each CNN-TT model configuration, the training was stopped after the validation loss reached plateau
(Figure E.1), and the model was retrieved at the ending epoch. For each retrieved model, we tested its
performance using SP1 A549 chromosome 1 positive and negative datasets (3785 samples for each dataset)
and calculated the receiver operating characteristic (ROC) area under curve (AUC).
Rank distribution
(r0, r1, . . . , rd)
Weight matrix dimensions











(1, 4, 4, 1) (4, 4, 5) × (4, 4, 60) 4861 1600 2.1% 0.969
(1, 8, 8, 1) (4, 4, 5) × (4, 4, 60) 6893 2688 3.5% 0.971
Table 6.2: The CNN-TT model predicted SP1 binding probability with high confidence, and the total
parameter number was largely reduced from the original CNN model. Columns from left to right: the ranks
(r0, r1, . . . , rd) of the TT-representation, where r0 = rd = 1; the weight matrix dimensions (m1, . . . ,md) and
(n1, . . . , nd), where M =
∏d
k=1mk and N =
∏d
k=1 nk are the total row and column numbers of the weight
matrix, respectively; the total parameter number in each CNN-TT model; the parameter number in the
TT-layer of each CNN-TT model; the percentage of the TT-layer parameter number to the original fully
connected layer parameter number (76880); the receiver operating characteristic (ROC) area under curve
(AUC) for each CNN-TT model.
6.3.2 The trained CNN-TT model predicts SP1 binding probability with high
confidence
We tested the performance of the CNN-TT model using A549 chr1 positive and negative datasets (3785
samples for each). For the configurations listed in Table 6.2, the receiver operating characteristic (ROC)
area under curve (AUC) are 0.969 and 0.971, respectively (Figure 6.4). We then applied the simulated-
annealing method [69] to obtain the motifs learned by the CNN-TT models. Interestingly, we found that
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apart from the SP1-like motif (Figure 6.5A, Figure E.2A, Figure 4.3A), the CNN-TT model also learned
the motif of HNF4A (Figure 6.6, Figure E.3), a transcription co-factor of SP1 implicated in previous studies
[120, 121]. These results together suggested that, although the total parameter number is largely reduced
compared to the original CNN model, our CNN-TT model predicted SP1 binding probability with high
confidence.
Model parameter number: 22621Model parameter number: 12965
Model parameter number: 6893Model parameter number: 4861A B
C DFigure 6.4: The trained CNN-TT models predict SP1 binding probability with high confidence in A549 chr1
test dataset. (A) The ROC curve of the CNN-TT model with configuration (r0, r1, r2, r3) = (1, 4, 4, 1) and
(m1,m2,m3) × (n1, n2, n3) = (4, 4, 5) × (4, 4, 60). The total parameter number is 4861, and the AUC is
0.969. (B) Similar to (A), but for configuration (r0, r1, r2, r3) = (1, 8, 8, 1) and (m1,m2,m3)× (n1, n2, n3) =
(4, 4, 5)× (4, 4, 60). The total parameter number is 6893, and the AUC is 0.971.
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Figure 6.5: The core motif learned by the CNN-TT model resembled the core motif of SP1 MA0079.3.
(A) One of the motifs learned by the CNN-TT model with configuration (r0, r1, r2, r3) = (1, 4, 4, 1) and
(m1,m2,m3)× (n1, n2, n3) = (4, 4, 5)× (4, 4, 60) (total parameter number 4861), visualized through a motif
logo obtained from WebLogo [79] 3. The core motif inside the red box resembles the core motif of SP1
MA0079.3 (Figure 4.3A). (B) The motif learned by the original CNN model in Section 4.3. The learned
motif from the CNN-TT model resembles the learned motif from the original CNN model.
Figure 6.6: Another motif learned by the CNN-TT model resembles the HNF4A motif MA0114.2.
(A) Another motif learned by the CNN-TT model with configuration (r0, r1, r2, r3) = (1, 4, 4, 1) and
(m1,m2,m3) × (n1, n2, n3) = (4, 4, 5) × (4, 4, 60) (total parameter number 4861), visualized through a mo-




In this chapter, we reviewed the idea of using TT-decomposition to compress the fully connected layer in
a neural network. The key for transforming the weight matrix W in a fully connected layer into the TT-
format is to rearrange the weight matrix as a multi-dimensional tensor, and utilize TT-decomposition to
approximate the tensor as a product of TT-cores. In the example of SP1 binding prediction, the ROC AUC
on the test dataset is above 0.969 for the CNN-TT model configurations, where the parameter number of
the TT-layer is as low as 2.1% of that in the original fully connected layer (Table 6.2). This suggested
the parameters in the weight matrix of the fully connected layer are highly redundant, and it is possible
for the neural network to capture the features of the input training data using a far more compact format.
We applied simulated-annealing method [69] to extract the motifs learned, and visualized the extracted
motifs using WebLogo [79] 3. Interestingly, we found that the CNN-TT model not only captured the motif
which resembled the known SP1 motif, but also captured the motif of HNF4A (Figure 6.6, Figure E.3), a
transcription co-factor of SP1 implicated in previous studies [120, 121]. These results together suggested
that, the TT-layer embedded convolutional neural network could capture the data features in the training
dataset with largely reduced parameter number; it relaxes the restriction of the large training dataset, and




After entering the 21 century, the rapid development of the massive parallel sequencing technology has pro-
vided unprecedented opportunities for cancer research. It allowed us to unveil the function of the genome
outside of the protein coding regions. With the help of various experimental methods such as ChIP-seq,
we could obtain heterogeneous information ranging from transcription factor binding sites, histone modi-
fications, to the 3D structure of the chromatin, all of which make the functional analysis of GWAS SNPs
possible.
In this thesis, we first presented the framework for identifying the causative consequences of LGG GWAS
SNPs. Based on the hypothesis that the GWAS loci contain causal SNPs that reside in functional regulatory
regions of the human genome and modulate the expression of target genes by directly perturbing the bind-
ing affinity of TFs, we incorporated heterogeneous genomic, epigenomic and transcriptomic high-throughput
sequencing data, and identified putative (causal SNP, target gene, TF) triplets. For 11q23.2 GWAS SNP
rs648044, we have shown that rs648044 may modulate the expression of ZBTB16 by perturbing the binding
affinity of MAFF. We also proposed that CIC, one of the most commonly mutated genes in IDH mut oligo-
dendrogliomas and located on chromosome 19q, is likely a direct transcriptional target of ZBTB16. These
observations suggested rs648044 might contribute to LGG pathogenesis through disrupting the potentially
important regulation network involving ZBTB16 and CIC. For 11q23.3 GWAS SNP rs12803321, we iden-
tified PHLDB1 as the putative target gene, and rs12225399, SP1/SP2 as the best candidate causal SNP,
TF pair. For 3q14.1 GWAS SNP rs11706832, a similar approach revealed SLC25A26, a gene belongs to the
mitochondrial carrier family and encodes a protein involved in transporting S-adenosylmethionine into the
mitochondria, as the target gene, and (rs11706832, SLC25A26, LEF1) as the best candidate triplet.
Owing to the rapid development of the high performance computing cluster and the graphics processing
unit (GPU), it has become approachable and convenient to apply deep learning method to prediction prob-
lems in the biological field. Deep learning approach like convolutional neural network permits the prediction
models to learn the internal data structures and features. In our study, we developed a deep learning ap-
proach for predicting the binding pattern of TFs when their ChIP-seq data are not available in the human
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brain. We integrated epigenomic information (DNase-seq signal) and genomic information (sequence) into
one convolutional filter, and trained the CNN on non-brain cell data. Using the trained model to evaluate
sequence and open chromatin information in brain tissues, we predicted the allele-specific binding preference
for SP1 at rs12225399, consistent with our motif analysis. Furthermore, by utilizing the simulated-annealing-
based optimization method, we confirmed the CNN-learned motif resembled the core binding motif of SP1.
A similar approach may benefit future functional genomics studies in the brain, where TF ChIP-seq data
are not readily available.
We at last presented the experiment of using TT-decomposition to compress the fully connected layer
in a convolutional neural network. In the example of SP1 binding prediction, we demonstrated that high
prediction accuracy was achieved using the TT-layer embedded CNN, where the parameter number of the
TT-layer was as low as 2.1% of that in the original fully connected layer. This suggested that the TT-layer
embedded convolutional neural network was able to capture the data features in the training dataset with
largely reduced parameter number. It relaxes the restriction of the large training dataset required by the
deep learning method in transcription factor binding prediction, and thus may have wider application in
future functional genomics studies.
Although we identified candidate (causal SNP, target gene, TF) triplets that might contribute to LGG
tumoregenesis in three case studies through the integrative computational framework, there were also certain
limitations in our study. For example, even though our eQTL analysis took copy number alteration as a
covariate in the linear model, it is possible that other uncharacterized somatic mutations that could alter
transcription levels and mRNA stability might have strongly perturbed the mRNA abundance in tumor
samples and complicated the target gene identification. Our study has focused on assessing the molecular
function of genetic variants in altering the binding affinity of TFs, however, other molecular functions such as
DNA methylation changes and protein modifications might also be important and need further investigation.
To facilitate the rapid identification of candidate (causal SNP, target gene, TF) triplets of the reported
LGG GWAS SNPs, we have summarized our results into an interactive user-friendly web database, ALG3
(http://education.knoweng.org/alg3/), devoloped by Dr. Mohith Manjunath et al. [51]. As far as we
are aware, there is no other work to date that presents the comprehensive characterization of the GWAS
SNPs of LGG. We hope our proposed (causal SNP, target gene, transcription factor) triplets could facilitate
additional analysis and expedite experimental validation. We also hope the physics-inspired deep learning
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Supplementary Material for Chapter
2
A.1 LGG GWAS SNPs and SNPs in high linkage disequilibrium
We obtained a list of GWAS SNPs from Melin et al. [12], passing the combined meta-analysis (eight studies)
P -value cutoff of 5×10−8 for non-glioblastoma gliomas. This yields 25 GWAS SNPs significantly associated
with LGG (Table A.1). 8 SNPs out of these 25 were also found to be significant (P < 5 × 10−8) in
glioblastoma. The median odds ratio for the 25 GWAS SNPs was 1.2, where 23 of the 25 SNPs had odds
ratio less than 1.5, typical of low-penetrance genetic variants [12]. We then used LDlink [58] to obtain all
SNPs in high linkage disequilibrium (r2 > 0.8, 1000 Genomes Phase 3, EUR population) with the 25 GWAS
SNPs and analyzed the functional footprinting of 280 SNPs in total.
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GWAS SNP ID Reference Allele Alternative Allele Risk Allele
rs10069690 C T T
rs10131032 G A G
rs11196067 A T A
rs11598018 C A C
rs11599775 G A G
rs11706832 A C C
rs12076373 G C G
rs1275600 T A T
rs12803321 G C G
rs1801591 G A A
rs2297440 T C C
rs2736100 C A C
rs3751667 C T T
rs4252707 G A A
rs4977756 G A G
rs498872 A G A
rs55705857 A G G
rs6010620 A G G
rs634537 T G G
rs648044 A G A
rs7107785 T C T
rs75061358 T G G
rs7572263 A G A
rs77633900 G C C
rs78378222 T G G
Table A.1: 25 GWAS SNPs significantly associated with LGG
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A.2 Motif permutation test
The motif permutation test described in Appendix A.2 was developed by Dr. Yi Zhang and Dr. Mohith
Manjunath [68]. The originally published method [68] is rephrased below.
Given a TF’s position probability matrix (PPM) of length L, the information content (IC) at position i








where pij denotes the probability of nucleotide j (j ∈ {A,C,G, T}) at position i, and qj denotes the
background frequency of nucleotide j. We used qA = 0.3, qC = 0.2, qG = 0.2 and qT = 0.3 throughout the
motif permutation test. For a genomic sequence S = s1s2 . . . sL (si denotes the nucleotide at position i of








Thus, if we assume the SNP at position k, and use S = s1s2 . . . sk . . . sL to denote the motif-matching se-
quence detected by FIMO, while using S′ = s1s2 . . . s
′
k . . . sL to denote the sequence containing an alternative
allele of the SNP, the score difference can be written as:




We then generated a null distribution of score change by introducing n (n = 5000) random single nucleotide
mutations at position i of sequence S, converting si to a random nucleotide s
a
i , where s
a
i ∈ {A,C,G, T},
i ∈ {1, 2, . . . , L}. In order to simulate neutral mutations, random mutations are introduced in two steps.
First, the choice of mutation position i in the sequence is determined by sampling from a distribution


















i ∈ {A,C,G, T}), Pm2(sai |i), is proportional to pisai in the position probability matrix:
Pm2(s
a
i |i) = pisai . (A.5)
Since the probability of converting si to s
a
i is equal to 0 when pisai = 0, instead of using the original position
probability matrix, we added a pseudocount of 5% to pij (i ∈ {1, 2, . . . , L}, j ∈ {A,C,G, T}), and normalized
the sum of probability at each position to 1. The neutral mutation probability is thus written as:
Pm(s
a
i ) = Pm1(i) · Pm2(sai |i). (A.6)
After performing the above steps, we now obtain the new sequence Sat for the t
th simulation (t ∈ {1, 2, . . . , n}).
We could then compute the score difference D(S,Sat ) for each mutated sequence S
a
t . The P -value of the




t=1 1{|D(S,Sat ) > D(S,S′)|}
n
. (A.7)
We repeated the calculation of P -value for 100 times, and reported the average P -value obtained. Setting
permutation test P -value threshold as 0.05, we thus selected all TFs whose binding affinity were significantly
perturbed by the SNP.
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B.1 Allele-specific ATAC-seq read counts of TCGA LGG
samples
For the ATAC-seq data, there were 13 samples in total with the aligned reads (hg38) in BAM format. We
extracted the read counts by allele at the rs648044 location using bcftools mpileup [76] option. We considered
only the bases with a Phred quality score of at least 20. Out of 13 samples, three were removed because the
imputed genotype status of rs648044 was not heterozygous. The genotype status of rs648044 in one of the
samples was imputed to be homozygous but was retained because the ATAC-seq reads showed high coverage
for both alleles at the SNP location. For each sample, the significance of the skew between the two alleles
was evaluated using a binomial test. The resulting P -values were then combined using the Fisher’s method
from the R package metap [122] (Table B.1).
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Total 518 429 1.00E-02 (Fisher’s
method)
Table B.1: Allele-specific ATAC-seq read counts covering the GWAS SNP rs648044 and the corresponding
two-sided binomial test P -values of TCGA LGG samples. The P -values were combined using the Fisher’s
method.
B.2 Electrophoretic Mobility Shift Assay (EMSA)
EMSA was performed with the mixture of the recombinant MafF protein and four different DNA oligonu-
cleotides: Positive Control (PC), rs648044 locus containing the A allele, rs648044 locus containing the G
allele, Negative Control (NC). The sequences of the oligonucleotides and recombinant MafF are given below.
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Two complementary oligonucleotide strands were mixed in a PCR tube and hybridized by increasing the tem-
perature to 98°C and lowering by 5°C every 5 minutes until the temperature reached 4°C using a thermocycler
(Mastercycler Personal, Eppendorf). For the binding of MafF, 4 pmole of the hybridized oligonucleotide and
32 pmole of MafF were mixed with 10 mM MgCl2 in T50 buffer (10 mM Tris-Cl, 50 mM NaCl, pH 8.0). For
MafF negative samples, the same materials were mixed, except for MafF. The resulting mixtures were incu-
bated at 37°C for 30 minutes. After the incubation, the mixtures were subjected to polyacrylamide gel elec-
trophoresis, fluorescently labeled by SYBR Gold Nucleic Acid Gel Stain (S11494, ThermoFisher) and visu-
alized on a UV illuminator (Dyna Light UV Transilluminator, Labnet International, Inc.). The recombinant
MafF is purchased from Abnova (GST-tag removed, catalog number: H00023764-Q01), and the recombinant
MafF sequence is: MSVDPLSSKALKIKRELSENTPHLSDEALMGLSVRELNRHLRGLSAEEVTRLKQR-
RRTLKNRGYAASCRVKRVCQKEELQKQKSELEREVDKLARENAAMRLELDALRGK. The oligonucleo-
tide sequences representing the rs648044 locus are given below, where the core binding motif of MAFF is
highlighted and underlined:
81 bp flanking sequence harboring the rs648044-A allele:
5’-CCTTGCACTGGCACATTCCTGCTGTTTTCTTCTGCTCAGCAGAGCCGAACGGCTCTCACT
TCCTGGCTAGCTCTGTGTGCT-3’
81 bp flanking sequence harboring the rs648044-G allele:
5’-CCTTGCACTGGCACATTCCTGCTGTTTTCTTCTGCTCAGCGGAGCCGAACGGCTCTCACT
TCCTGGCTAGCTCTGTGTGCT-3’
The control sequences were designed based on ChIP-seq results (Appendix B.3). All oligonucleotides
were purchased from Integrated DNA Technologies.
B.3 EMSA experiment MAFF positive control (PC) and
negative control (NC) sequences
We first obtained MAFF ChIP-seq peaks in HepG2, K562 and HelaS3 cell lines from ENCODE (HepG2:
ENCFF611VKE; K562: ENCFF864KPF; HelaS3: ENCFF575MOS). We then ranked the peaks by q-value
in each cell type to obtain top peak regions. We intersected the top peak regions and scanned the sequences
using FIMO [71], keeping only the consensus peaks containing a MAFF binding motif. Upon visual inspec-
tion of raw ChIP-seq signals of the top remaining candidates, we chose chr14:77423081-77423161 (hg19) as
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the 81bp-long positive control sequence centered around a MAFF core binding motif (TCAGCA). For the
negative control sequence, we first scanned the 81 bp flanking sequence harboring the rs648044-A allele and
obtained all sub-sequences which might partially contain a core MAFF motif. We then randomly permuted
the nucleotides in those subsequences. We checked that the resulting negative control sequence satisfied the
following two criteria: (1) there were no more than three adjacent nucleotides of MAFF core binding motif
(TCAGCA or its reverse compliment TGCTGA); (2) the GC content of the negative control sequence was
approximately the same as the original sequence harboring the rs648044-A allele. The positive control and
negative control sequences are provided below, where the core binding motif of MAFF is highlighted and







B.4 Cell Culture, RNAi and RNA expression
The cell line SF10417 (from UCSF) derived from a human IDH1R132H mutant, TERT promoter-mutant,
1p/19q-codeleted oligodendroglioma was used to assess the effect of MAFF knockdown on ZBTB16 and
NCAM1 expression. The cells were grown in NeuroCult NS-A media (STEMCELL Technologies) supple-
mented with L-Glutamine, B27, N2, Sodium Pyruvate and Pen/Strep (Life Technologies) in the presence of
growth factors bFGF, EGF (STEMCELL Technologies), and PDGFAA (PeproTech). Lentivirus were pro-
duced with short-hairpin RNA (shRNA) with either a non-target shRNA control vector or a vector designed
to reduce the expression of MAFF (n = 3 independent constructs, Sigma Mission). Cells were infected
with a MOI of 1, followed by selection of transduced cells with puromycin. Populations were subcloned and
total RNA was isolated for three independent clones for each of the vectors (Qiagen). First strand cDNA
synthesis was completed with SuperScript IV VILO (Invitrogen) and gene expression was measured with
TaqMan probes according to manufacture guidelines for genes 18S, MAFF, ZBTB16 and NCAM1 (Applied
Biosystems).
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B.5 The effect of MAFF RNAi knockdown on NCAM1
expression
Figure B.1: The results of MAFF RNAi knockdown experiment showing insignificant effect on NCAM1
expression. One-sided t-test P -value between the control group and the combined group of three independent
shRNA clones is shown on top of the figure.
B.6 CIC inactivating mutations
We acquired the mutation calls from the 4 somatic variant calling pipelines: MuSE [123], MuTect2 [124],
SomaticSniper [125] and VarScan2 [126], available in the GDC Data Portal [30]. For each of the 4 pipelines,
we then obtained all CIC inactivating mutations based on whether the PolyPhen column contained the
“probably damaging” term or the IMPACT column was “HIGH” [127]. To reduce false positives, we retained
only those inactivating mutation calls detected by at least 2 of the 4 pipelines.
B.7 ZBTB16 ChIP-seq data from Gene Expression Omnibus
ZBTB16 (PLZF) ChIP-seq datasets were obtained from Gene Expression Omnibus accession numbers
GSE125166 (human mesenchymal stem cells), GSE75115 (human endometrial stromal cells) and GSE109619
(acute myelogenous leukemia cell line KG1).
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C.1 GWAS SNP rs12803321 and its high LD SNPs
RS number Chromosome Position
(hg19)
Alleles r2 GWAS SNP
correlated
alleles
rs12803321 11 118480115 G/C 1 -
rs67307131 11 118480223 T/C 0.98 G=T, C=C
rs12225399 11 118480285 G/C 0.97 G=G, C=C
rs7125115 11 118478330 G/A 0.90 G=G, C=A
Table C.1: GWAS SNP rs12803321 and its three high LD (r2 > 0.8, 1000 Genomes Phase 3, EUR) SNPs.
C.2 Phased allele-specific expression of PHLDB1
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P = 8.97 x 10-5 P = 5.83 x 10-3 P = 1.88 x 10-2
P = 1.88 x 10-8 P = 2.60 x 10-4 P = 1.54 x 10-5
























































42 cases, Chr11:118477367 63 cases, Chr11:118478330 22 cases, Chr11:118505090
55 cases, Chr11:118509668 56 cases, Chr11:118510562      56 cases, Chr11:118511352
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 Same direction with eQTL GWAS
A
P = 1.08 x 10-5 P = 1.30 x 10-2 P = 9.60 x 10-7





























56 cases, Chr11:118511757 22 cases, Chr11:118512162 32 cases, Chr11:118514625
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 Same direction with eQTL GWAS
B
Figure C.1: (A, B) Phased allele-specific transcription pattern of PHLDB1 at 9 exonic SNPs in the TCGA-
LGG “IDH mut only” subgroup. All 9 SNPs show higher transcription emanating from the rs12803321-C
haplotype, consistent with the eQTL analysis. For each exonic SNP, RNA-Seq read count differences between
the two chromosomes harboring the rs12803321-G allele and the rs12803321-C allele are sorted across patients
and shown as bar plots. The P -value from the Wilcoxon signed-rank sum test is shown at the top of each
bar plot. The genomic locations of these 9 exonic SNPs are shown in the GENCODE Version 19 track.
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C.3 Candidate TFs perturbed by rs7125115
motif
from
motif to motif id motif
source






118478329 118478346 MA0729.1 JASPAR RARA - A 0.000995 0.04
118478320 118478335 MA0868.1 JASPAR SOX8 + A 0.000656 0.02
Table C.2: Motifs of candidate TFs perturbed by rs7125115. Columns from left to right: motif start
coordinate in chr11 (hg19); motif end coordinate in chr11 (hg19); motif id from one of the four databases
- JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; motif source, one of the four
databases - JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; transcription factor
name; strand harboring the motif; rs7125115 allele harbored by the motif; P -value from Fimo output;











All TCGA-LGG samples RARA 9.72 264 172 42 0.23 0.12 0.21
IDH mut only and TP RARA 9.77 195 105 22 0.25 0.30 0.42
IDH mut only RARA 9.68 118 65 10 0.11 0.32 0.34
TP RARA 9.91 77 40 12 0.32 0.24 0.63
All TCGA-LGG samples SOX8 13.49 264 172 42 0.24 0.39 0.43
IDH mut only and TP SOX8 13.96 195 105 22 0.33 0.49 0.27
IDH mut only SOX8 13.76 118 65 10 0.31 0.59 0.25
TP SOX8 14.27 77 40 12 0.25 0.34 0.66
Table C.3: The Pearson’s correlation coefficient (r) between TF and PHLDB1 stratified into rs7125115
GG, GA and AA genotype groups. Columns from left to right: patient group; transcription factor name;
TF average expression, defined as log2(RSEM + 1); patient number in GG genotype group; patient number
in GA genotype group; patient number in AA genotype group; Pearson’s correlation coefficient in GG
genotype group; Pearson’s correlation coefficient in GA genotype group; Pearson’s correlation coefficient in
AA genotype group.
Figure C.2: Motif logo of each candidate TF listed in Table C.2 and variants of the flanking sequences
harboring rs7125115 risk allele G (C for - strand) or rs7125115 non-risk allele A (T for - strand). TFs are
predicted to have higher binding affinity to the sequences on top than the sequences at bottom.
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C.4 Candidate TFs perturbed by rs12803321
motif
from
motif to motif id motif
source









































TP53 - C 0.000554 0.035
Table C.4: Motifs of candidate TFs perturbed by rs12803321. Columns from left to right: motif start
coordinate in chr11 (hg19); motif end coordinate in chr11 (hg19); motif id from one of the four databases
- JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; motif source, one of the four
databases - JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; transcription factor
name; strand harboring the motif; rs12803321 allele harbored by the motif; P -value from Fimo output;












All TCGA-LGG samples FOSB 7.55 273 172 29 -0.23 -0.11 -0.06
IDH mut only and TP FOSB 7.46 200 106 17 -0.18 -0.12 -0.08
IDH mut only FOSB 7.40 120 65 8 -0.175 -0.172 0.048
TP FOSB 7.54 80 41 9 -0.18 -0.13 -0.37
All TCGA-LGG samples RBPJ 9.86 273 172 29 0.25 0.28 0.47
IDH mut only and TP RBPJ 10.00 200 106 17 0.25 0.21 0.31
IDH mut only RBPJ 10.03 120 65 8 0.29 0.29 0.36
TP RBPJ 9.94 80 41 9 0.21 0.25 -0.07
All TCGA-LGG samples RXRB 10.54 273 172 29 0.14 0.25 0.25
IDH mut only and TP RXRB 10.63 200 106 17 0.24 0.28 0.16
IDH mut only RXRB 10.58 120 65 8 0.14 0.10 0.29
TP RXRB 10.71 80 41 9 0.25 0.41 0.37
All TCGA-LGG samples SP2 9.54 273 172 29 0.24 0.22 0.47
IDH mut only and TP SP2 9.55 200 106 17 0.25 0.34 0.47
IDH mut only SP2 9.59 120 65 8 0.24 0.28 0.36
TP SP2 9.51 80 41 9 0.35 0.53 0.28
All TCGA-LGG samples TFE3 11.05 273 172 29 -0.18 -0.08 -0.12
IDH mut only and TP TFE3 11.03 200 106 17 -0.14 -0.11 -0.03
IDH mut only TFE3 11.11 120 65 8 -0.11 -0.05 0.14
TP TFE3 10.92 80 41 9 -0.09 -0.16 -0.07
All TCGA-LGG samples TP53 9.97 273 172 29 0.26 0.08 0.21
IDH mut only and TP TP53 10.00 200 106 17 0.25 0.17 0.42
IDH mut only TP53 9.85 120 65 8 0.27 0.13 0.57
TP TP53 10.22 80 41 9 0.11 0.22 0.35
Table C.5: The Pearson’s correlation coefficient (r) between TF and PHLDB1 stratified into rs12803321
GG, GC and CC genotype groups. Columns from left to right: patient group; transcription factor name;
TF average expression, defined as log2(RSEM + 1); patient number in GG genotype group; patient number
in GC genotype group; patient number in CC genotype group; Pearson’s correlation coefficient in GG
genotype group; Pearson’s correlation coefficient in GC genotype group; Pearson’s correlation coefficient in
CC genotype group.
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Figure C.3: Motif logo of each candidate TF listed in Table C.4 and variants of the flanking sequences
harboring rs12803321 risk allele G (C for - strand) or rs12803321 non-risk allele C (G for - strand). TFs are
predicted to have higher binding affinity to the sequences on top than the sequences at bottom.
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C.5 Candidate TFs perturbed by rs67307131
motif
from
motif to motif id motif
source












AHR - C 0.000233 0.0061
118480220 118480227 MA0259.1 JASPAR ARNT
::HIF1A


















- C 9.20E-05 0.013
118480215 118480228 EGR1
DBD
jolma2013 EGR1 + C 0.00046 0.00056
118480215 118480228 EGR1 full jolma2013 EGR1 + C 0.000629 0.0038
118480216 118480226 EGR1 full HOCO-
MOCO
EGR1 - C 0.000591 0.0053






MESP1 - T 0.00037 0.014
118480217 118480226 MESP1
DBD






NRF1 - C 0.000714 0.004
118480215 118480225 MA0506.1 JASPAR NRF1 - C 0.000655 0.032






BHLHE40 - T 0.000792 0.013
118480213 118480226 GMEB2
DBD 2



















KLF15 - C 0.000667 0.01
Table C.6: Motifs of candidate TFs perturbed by rs67307131. Columns from left to right: motif start
coordinate in chr11 (hg19); motif end coordinate in chr11 (hg19); motif id from one of the four databases
- JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; motif source, one of the four
databases - JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; transcription factor
name; strand harboring the motif; rs67307131 allele harbored by the motif; P -value from Fimo output;












All TCGA-LGG samples AHR 8.00 277 167 30 -0.03 -0.13 -0.39
IDH mut only and TP AHR 7.89 202 102 17 -0.07 -0.23 -0.15
IDH mut only AHR 8.13 122 62 8 -0.02 -0.17 -0.20
TP AHR 7.5 80 40 9 0.019 -0.26 -0.30
All TCGA-LGG samples ARNT 9.55 277 167 30 -0.07 0.09 0.12
IDH mut only and TP ARNT 9.57 202 102 17 0.098 0.13 0.046
IDH mut only ARNT 9.58 122 62 8 0.014 0.47 0.043
TP ARNT 9.55 80 40 9 0.31 -0.53 0.46
All TCGA-LGG samples HNF1A 12.07 277 167 30 -0.078 -0.12 0.04
IDH mut only and TP HNF1A 12.09 202 102 17 -0.008 -0.03 -0.16
IDH mut only HNF1A 12.13 122 62 8 0.04 0.018 -0.29
TP HNF1A 12.02 80 40 9 -0.04 -0.055 -0.20
All TCGA-LGG samples ARNT2 12.91 277 167 30 -0.25 0.07 0.00
IDH mut only and TP ARNT2 12.92 202 102 17 -0.17 -0.009 -0.45
IDH mut only ARNT2 12.87 122 62 8 -0.24 0.0055 -0.56
TP ARNT2 13.01 80 40 9 -0.11 -0.16 -0.010
All TCGA-LGG samples EGR1 11.03 277 167 30 -0.15 -0.03 -0.064
IDH mut only and TP EGR1 10.78 202 102 17 -0.15 0.043 0.11
IDH mut only EGR1 11.11 122 62 8 -0.004 0.14 0.52
TP EGR1 10.30 80 40 9 -0.225 -0.122 -0.57
All TCGA-LGG samples MNT 9.44 277 167 30 -0.09 0.09 -0.17
IDH mut only and TP MNT 9.48 202 102 17 -0.06 0.11 -0.26
IDH mut only MNT 9.48 122 62 8 -0.16 0.13 -0.17
TP MNT 9.48 80 40 9 0.08 0.09 -0.42
All TCGA-LGG samples MESP1 6.19 277 167 30 -0.03 0.04 -0.03
IDH mut only and TP MESP1 6.22 202 102 17 -0.09 0.009 0.24
IDH mut only MESP1 6.11 122 62 8 -0.17 0.07 0.45
TP MESP1 6.38 80 40 9 -0.07 -0.17 0.35















All TCGA-LGG samples NRF1 8.77 277 167 30 0.11 0.091 -0.16
IDH mut only and TP NRF1 8.78 202 102 17 0.14 0.28 -0.04
IDH mut only NRF1 8.84 122 62 8 0.15 0.36 -0.39
TP NRF1 8.69 80 40 9 0.29 0.36 -0.28
All TCGA-LGG samples TBR1 5.07 277 167 30 -0.18 -0.15 -0.26
IDH mut only and TP TBR1 5.07 202 102 17 -0.18 -0.15 -0.36
IDH mut only TBR1 4.80 122 62 8 -0.13 -0.18 -0.67
TP TBR1 5.46 80 40 9 -0.31 -0.24 0.008
All TCGA-LGG samples BHLHE40 9.85 277 167 30 -0.33 -0.33 -0.45
IDH mut only and TP BHLHE40 9.60 202 102 17 -0.35 -0.37 -0.21
IDH mut only BHLHE40 9.65 122 62 8 -0.40 -0.39 -0.41
TP BHLHE40 9.54 80 40 9 -0.24 -0.33 0.05
All TCGA-LGG samples GMEB2 8.82 277 167 30 0.09 0.1 -0.20
IDH mut only and TP GMEB2 8.82 202 102 17 0.13 0.25 0.14
IDH mut only GMEB2 8.74 122 62 8 -0.09 0.08 0.16
TP GMEB2 8.95 80 40 9 0.21 0.43 0.19
All TCGA-LGG samples SP1 10.38 277 167 30 0.20 0.098 0.17
IDH mut only and TP SP1 10.38 202 102 17 0.22 0.20 0.21
IDH mut only SP1 10.43 122 62 8 0.31 0.17 -0.34
TP SP1 10.32 80 40 9 0.13 0.39 0.18
All TCGA-LGG samples KLF15 10.33 277 167 30 0.055 0.23 0.095
IDH mut only and TP KLF15 10.38 202 102 17 0.14 0.19 -0.15
IDH mut only KLF15 10.22 122 62 8 0.086 0.27 0.06
TP KLF15 10.60 80 40 9 0.11 0.007 -0.014
Table C.7: The Pearson’s correlation coefficient (r) between TF and PHLDB1 stratified into rs67307131
TT, TC and CC genotype groups. Columns from left to right: patient group; transcription factor name;
TF average expression, defined as log2(RSEM + 1); patient number in TT genotype group; patient number
in TC genotype group; patient number in CC genotype group; Pearson’s correlation coefficient in TT
genotype group; Pearson’s correlation coefficient in TC genotype group; Pearson’s correlation coefficient in
CC genotype group.
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Figure C.4: Motif logo of each candidate TF listed in Table C.6 and variants of the flanking sequences
harboring rs67307131 risk allele T (A for - strand) or rs67307131 non-risk allele C (G for - strand). TFs are
predicted to have higher binding affinity to the sequences on top than the sequences at bottom.
98
Figure C.5: (Figure C.4 continued) - motif logo of each candidate TF listed in Table C.6 and variants of the
flanking sequences harboring rs67307131 risk allele T (A for - strand) or rs67307131 non-risk allele C (G for
- strand). TFs are predicted to have higher binding affinity to the sequences on top than the sequences at
bottom.
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Figure C.6: (Figure C.4, C.5 continued) - motif logo of each candidate TF listed in Table C.6 and variants of
the flanking sequences harboring rs67307131 risk allele T (A for - strand) or rs67307131 non-risk allele C (G
for - strand). TFs are predicted to have higher binding affinity to the sequences on top than the sequences
at bottom.
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C.6 Other candidate TFs perturbed by rs12225399
motif
from




























IRX2 - C 0.000942 0.00044








































DBP + G 0.000763 0.017






































PKNOX2 - C 0.000114 0.055
Caption in the next page
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Table C.8: Motifs of other candidate TFs perturbed by rs12225399. Columns from left to right: motif start
coordinate in chr11 (hg19); motif end coordinate in chr11 (hg19); motif id from one of the four databases
- JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; motif source, one of the four
databases - JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; transcription factor
name; strand harboring the motif; rs12225399 allele harbored by the motif; P -value from Fimo output;















All TCGA-LGG samples PATZ1 10.85 281 166 29 0.14 0.24 0.45
IDH mut only and TP PATZ1 11.01 202 103 16 0.23 0.32 0.52
IDH mut only PATZ1 10.99 122 62 8 0.20 0.29 0.28
TP PATZ1 11.03 80 41 8 0.24 0.37 0.70
All TCGA-LGG samples IRX2 5.91 281 166 29 -0.07 0.09 0.32
IDH mut only and TP IRX2 6.49 202 103 16 -0.06 0.073 0.27
IDH mut only IRX2 7.33 122 62 8 0.01 0.20 -0.35
TP IRX2 5.24 80 41 8 0.06 0.15 0.32
All TCGA-LGG samples EGR3 8.34 281 166 29 -0.25 -0.03 0.11
IDH mut only and TP EGR3 8.26 202 103 16 -0.23 -0.11 0.065
IDH mut only EGR3 8.53 122 62 8 -0.11 -0.019 0.19
TP EGR3 7.86 80 41 8 -0.31 -0.30 -0.68
All TCGA-LGG samples ZNF740 9.82 281 166 29 0.16 0.25 0.093
IDH mut only and TP ZNF740 9.88 202 103 16 0.28 0.26 -0.13
IDH mut only ZNF740 9.85 122 62 8 0.22 0.17 -0.36
TP ZNF740 9.94 80 41 8 0.29 0.45 -0.03
All TCGA-LGG samples ZNF784 6.93 281 166 29 0.14 0.11 -0.18
IDH mut only and TP ZNF784 6.90 202 103 16 0.08 0.15 0.40
IDH mut only ZNF784 7.02 122 62 8 0.08 0.23 0.44
TP ZNF784 6.73 80 41 8 0.19 0.19 0.16
All TCGA-LGG samples TFAP2C 2.40 281 166 29 -0.11 -0.093 -0.014
IDH mut only and TP TFAP2C 2.21 202 103 16 -0.13 -0.23 -0.034
IDH mut only TFAP2C 2.39 122 62 8 -0.14 -0.14 -0.10
TP TFAP2C 1.96 80 41 8 -0.03 -0.36 -0.41
All TCGA-LGG samples MAZ 12.01 281 166 29 0.07 0.12 0.001
IDH mut only and TP MAZ 12.04 202 103 16 0.08 0.165 0.255
IDH mut only MAZ 11.98 122 62 8 -0.03 0.158 0.257
TP MAZ 12.14 80 41 8 0.12 0.16 0.31
All TCGA-LGG samples DBP 8.86 281 166 29 -0.25 0.015 -0.086
IDH mut only and TP DBP 8.88 202 103 16 -0.24 -0.11 0.35
IDH mut only DBP 9.02 122 62 8 -0.25 -0.11 0.37
TP DBP 8.67 80 41 8 -0.11 -0.02 0.36
All TCGA-LGG samples RXRA 11.04 281 166 29 -0.18 -0.04 -0.28
IDH mut only and TP RXRA 11.02 202 103 16 -0.10 -0.08 -0.32
IDH mut only RXRA 11.06 122 62 8 -0.11 0.017 -0.31
TP RXRA 10.96 80 41 8 -0.05 -0.17 -0.31
All TCGA-LGG samples RARA 9.73 281 166 29 0.23 0.14 0.15
IDH mut only and TP RARA 9.78 202 103 16 0.24 0.28 0.40
IDH mut only RARA 9.68 122 62 8 0.11 0.28 0.41
TP RARA 9.91 80 41 8 0.33 0.25 0.59
All TCGA-LGG samples ZNF219 9.97 281 166 29 0.30 0.36 0.18
IDH mut only and TP ZNF219 10.05 202 103 16 0.29 0.38 0.11
IDH mut only ZNF219 9.82 122 62 8 0.12 0.27 -0.21
TP ZNF219 10.39 80 41 8 0.36 0.45 0.78















IDH mut only and TP MYC 10.27 202 103 16 0.22 0.38 0.44
IDH mut only MYC 10.29 122 62 8 0.16 0.31 0.46
TP MYC 10.25 80 41 8 0.35 0.52 0.17
All TCGA-LGG samples TCF12 12.89 281 166 29 0.15 0.27 0.45
IDH mut only and TP TCF12 13.15 202 103 16 0.20 0.29 0.22
IDH mut only TCF12 13.06 122 62 8 0.25 0.26 0.36
TP TCF12 13.27 80 41 8 0.06 0.29 0.19
All TCGA-LGG samples TCF3 10.82 281 166 29 0.16 0.18 0.054
IDH mut only and TP TCF3 10.89 202 103 16 0.17 0.30 0.30
IDH mut only TCF3 10.96 122 62 8 0.19 0.30 0.12
TP TCF3 10.79 80 41 8 0.23 0.39 0.25
All TCGA-LGG samples TFEB 9.62 281 166 29 0.52 0.55 0.58
IDH mut only and TP TFEB 9.66 202 103 16 0.50 0.42 0.67
IDH mut only TFEB 9.70 122 62 8 0.53 0.40 0.76
TP TFEB 9.60 80 41 8 0.50 0.54 0.48
All TCGA-LGG samples USF1 10.23 281 166 29 0.14 0.10 -0.19
IDH mut only and TP USF1 10.25 202 103 16 0.12 0.12 0.19
IDH mut only USF1 10.24 122 62 8 0.11 0.14 0.57
TP USF1 10.27 80 41 8 0.10 0.12 -0.12
All TCGA-LGG samples USF2 11.53 281 166 29 -0.025 0.05 -0.05
IDH mut only and TP USF2 11.51 202 103 16 -0.08 -0.016 0.36
IDH mut only USF2 11.80 122 62 8 0.06 0.09 0.51
TP USF2 11.06 80 41 8 0.16 0.15 0.12
All TCGA-LGG samples ZEB2 11.82 281 166 29 0.39 0.42 0.54
IDH mut only and TP ZEB2 11.89 202 103 16 0.45 0.38 0.15
IDH mut only ZEB2 11.82 122 62 8 0.53 0.23 0.06
TP ZEB2 11.99 80 41 8 0.29 0.57 0.14
All TCGA-LGG samples THRB 8.91 281 166 29 -0.29 -0.12 -0.24
IDH mut only and TP THRB 8.87 202 103 16 -0.25 -0.21 -0.72
IDH mut only THRB 8.93 122 62 8 -0.26 -0.20 -0.66
TP THRB 9.07 80 41 8 -0.32 -0.41 -0.77
All TCGA-LGG samples PKNOX2 9.41 281 166 29 0.04 0.23 0.31
IDH mut only and TP PKNOX2 9.53 202 103 16 0.04 0.22 0.11
IDH mut only PKNOX2 9.49 122 62 8 0.00 0.26 0.01
TP PKNOX2 9.60 80 41 8 0.05 0.081 0.001
Table C.9: The Pearson’s correlation coefficient (r) between TF and PHLDB1 stratified into rs12225399
GG, GC and CC genotype groups. Columns from left to right: patient group; transcription factor name;
TF average expression, defined as log2(RSEM + 1); patient number in GG genotype group; patient number
in GC genotype group; patient number in CC genotype group; Pearson’s correlation coefficient in GG
genotype group; Pearson’s correlation coefficient in GC genotype group; Pearson’s correlation coefficient in
CC genotype group.
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Figure C.7: Motif logo of each candidate TF listed in Table C.8 and variants of the flanking sequences
harboring rs12225399 risk allele G (C for - strand) or rs12225399 non-risk allele C (G for - strand). TFs are
predicted to have higher binding affinity to the sequences on top than the sequences at bottom.
Figure C.8: (Figure C.7 continued) - motif logo of each candidate TF listed in Table C.8 and variants of the
flanking sequences harboring rs12225399 risk allele G (C for - strand) or rs12225399 non-risk allele C (G for
- strand). TFs are predicted to have higher binding affinity to the sequences on top than the sequences at
bottom.
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H1-hESC ENCFF807SXP ENCFF899UPI ENCFF317TBZ ENCFF721YVP ENCFF433IIE
HEK293T ENCFF910QHN ENCFF716SFD ENCFF240PYU ENCFF730EIH ENCFF306LPM
HepG2 ENCFF571RHF ENCFF867UYB ENCFF573ALP ENCFF894RIX ENCFF732DBE
Liver ENCFF286LYP ENCFF219YEB ENCFF017YUI ENCFF027RDL ENCFF672UVA
K562 ENCFF623AFX ENCFF789QUY ENCFF300XUA ENCFF103ESU ENCFF591WIF
MCF-7 ENCFF382GKE ENCFF216EVD ENCFF193MKL ENCFF546ASI ENCFF475AXY
A549 ENCFF475BVB ENCFF723TWJ ENCFF348RKC ENCFF831GEW ENCFF715NIC















Table C.11: Fetal Brain DNase-seq raw signal files from REMC
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D.1 GWAS SNP rs11706832 and its high LD SNPs
RS number Chromosome Position
(hg19)
Alleles r2 GWAS SNP
correlated
alleles
rs11706832 3 66502981 A/C 1 -
rs56300148 3 66497714 T/C 0.93 A=T, C=C
rs4402869 3 66507444 G/A 0.87 A=G, C=A
rs11717516 3 66508132 G/A 0.86 A=G, C=A
Table D.1: GWAS SNP rs11706832 and its three high LD (r2 > 0.8, 1000 Genomes Phase 3, EUR) SNPs.

































































































r = -0.35 r = -0.24 r = -0.18
Pearson’s
correlation coefficient
Figure D.1: The GWAS SNP rs11706832 likely modulates SLC25A26 expression through perturbing the
binding affinity of LEF1. (A) LEF1 motif MA0768.1 (JASPAR [24]) and two versions of the flanking sequence
harboring the rs11706832-A and rs11706832-C alleles. (B) Scatter plots of LEF1 vs. SLC25A26 expression
in the three genotypes of rs11706832 in the combined TCGA-LGG “IDH mut only” and triple-positive group.
(C) Scatter plots of LEF1 vs. SLC25A26 expression in the three genotypes of rs11706832 in all TCGA-LGG
samples.
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D.3 Other candidate TFs perturbed by rs11706832
motif
from
























NR2F2 + A 0.000568 0.0099















NR6A1 + A 0.00082 0.037
Table D.2: Motifs of other candidate TFs perturbed by rs11706832. Columns from left to right: motif start
coordinate in chr3 (hg19); motif end coordinate in chr3 (hg19); motif id from one of the four databases -
JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; motif source, one of the four
databases - JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; transcription factor
name; strand harboring the motif; rs11706832 allele harbored by the motif; P -value from Fimo output;














All TCGA-LGG samples NR2F2 7.98 132 232 143 -0.31 -0.29 -0.12
IDH mut only and TP NR2F2 7.73 64 167 109 -0.16 -0.16 -0.073
IDH mut only NR2F2 7.88 39 95 69 0.007 -0.11 -0.07
TP NR2F2 7.51 25 72 40 -0.42 -0.25 -0.06
All TCGA-LGG samples ESRRB 2.98 132 232 143 -0.26 -0.20 -0.10
IDH mut only and TP ESRRB 2.86 64 167 109 -0.30 -0.16 -0.06
IDH mut only ESRRB 3.02 39 95 69 -0.41 -0.25 -0.12
TP ESRRB 2.63 25 72 40 0.02 0.048 0.05
All TCGA-LGG samples NFATC1 7.49 132 232 143 -0.42 -0.15 -0.10
IDH mut only and TP NFATC1 7.31 64 167 109 -0.25 -0.006 -0.11
IDH mut only NFATC1 7.99 39 95 69 -0.26 -0.034 -0.17
TP NFATC1 6.30 25 72 40 -0.09 0.07 -0.045
All TCGA-LGG samples NR6A1 2.81 132 232 143 -0.05 -0.09 -0.3
IDH mut only and TP NR6A1 2.81 64 167 109 -0.31 -0.08 -0.26
IDH mut only NR6A1 3.00 39 95 69 -0.28 -0.14 -0.17
TP NR6A1 2.53 25 72 40 -0.27 0.01 -0.33
Caption on the next page.
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Table D.3: The Pearson’s correlation coefficient (r) between TF and SLC25A26 stratified into rs11706832
AA, AC and CC genotype groups. Columns from left to right: patient group; transcription factor name;
TF average expression, defined as log2(RSEM + 1); patient number in AA genotype group; patient number
in AC genotype group; patient number in CC genotype group; Pearson’s correlation coefficient in AA
genotype group; Pearson’s correlation coefficient in AC genotype group; Pearson’s correlation coefficient in
CC genotype group.
Figure D.2: Motif logo of each candidate TF listed in Table D.2 and variants of the flanking sequences
harboring rs11706832 risk allele C (G for - strand) or rs11706832 non-risk allele A (T for - strand). TFs are
predicted to have higher binding affinity to the sequences on top than the sequences at bottom.
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D.4 Candidate TFs perturbed by rs4402869
motif
from
















TP63 - G 5.04E-05 0.0049










- G 0.000803 0.024
66507432 66507451 MA0066.1 JASPAR PPARG + G 0.000366 0.033
66507433 66507449 ESR1 DBD jolma2013 ESR1 - G 0.000944 0.017
66507443 66507455 MA0815.1 JASPAR TFAP2C + G 0.00099 0.01
66507443 66507455 MA0815.1 JASPAR TFAP2C - G 0.00099 0.01
Table D.4: Motifs of candidate TFs perturbed by rs4402869. Columns from left to right: motif start
coordinate in chr3 (hg19); motif end coordinate in chr3 (hg19); motif id from one of the four databases -
JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; motif source, one of the four
databases - JASPAR [72], HOCOMOCOv10 [73], TRANSFAC [74] and Jolma2013 [75]; transcription factor
name; strand harboring the motif; rs4402869 allele harbored by the motif; P -value from Fimo output;















All TCGA-LGG samples TP63 2.50 133 212 120 -0.225 -0.26 -0.28
IDH mut only and TP TP63 2.24 68 156 91 -0.25 -0.28 -0.18
IDH mut only TP63 2.20 41 93 57 -0.21 -0.25 -0.19
TP TP63 2.31 27 63 34 -0.38 -0.33 -0.18
All TCGA-LGG samples GLI2 7.09 133 212 120 -0.23 -0.091 -0.24
IDH mut only and TP GLI2 6.94 68 156 91 0.18 0.046 -0.22
IDH mut only GLI2 7.23 41 93 57 0.45 -0.058 -0.007
TP GLI2 6.50 27 63 34 -0.23 0.22 -0.42
All TCGA-LGG samples GLI3 7.87 133 212 120 -0.51 -0.077 -0.30
IDH mut only and TP GLI3 7.60 68 156 91 -0.24 -0.009 -0.32
IDH mut only GLI3 8.04 41 93 57 0.21 -0.05 -0.23
TP GLI3 6.93 27 63 34 -0.50 0.018 -0.42
All TCGA-LGG samples PPARG 5.01 133 212 120 -0.30 -0.13 0.075
IDH mut only and TP PPARG 4.83 68 156 91 -0.11 -0.063 0.23
IDH mut only PPARG 4.98 41 93 57 -0.077 -0.054 0.27
TP PPARG 4.61 27 63 34 -0.14 -0.09 0.23
All TCGA-LGG samples ESR1 3.5 133 212 120 -0.20 -0.16 -0.078
IDH mut only and TP ESR1 3.39 68 156 91 -0.18 -0.079 -0.025
IDH mut only ESR1 3.33 41 93 57 -0.18 0.019 -0.032
TP ESR1 3.48 27 63 34 -0.22 -0.23 -0.017
All TCGA-LGG samples TFAP2C 2.39 133 212 120 -0.29 0.024 0.013
IDH mut only and TP TFAP2C 2.23 68 156 91 -0.15 0.015 0.078
IDH mut only TFAP2C 2.42 41 93 57 0.03 0.035 0.27
TP TFAP2C 1.94 27 63 34 -0.38 -0.034 -0.11
Table D.5: The Pearson’s correlation coefficient (r) between TF and SLC25A26 stratified into rs4402869
GG, GA and AA genotype groups. Columns from left to right: patient group; transcription factor name;
TF average expression, defined as log2(RSEM + 1); patient number in GG genotype group; patient number
in GA genotype group; patient number in AA genotype group; Pearson’s correlation coefficient in GG
genotype group; Pearson’s correlation coefficient in GA genotype group; Pearson’s correlation coefficient in
AA genotype group.
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Figure D.3: Motif logo of each candidate TF listed in Table D.4 and variants of the flanking sequences
harboring rs4402869 risk allele A (T for - strand) or rs4402869 non-risk allele G (C for - strand). TFs are
predicted to have higher binding affinity to the sequences on top than the sequences at bottom.
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Appendix E
Supplementary Material for Chapter
6
E.1 Related theorems and corollaries
The theorems and corollaries listed below (Theorem E.1.1, Theorem E.1.2, Corollary E.1.2.1, Corollary E.1.2.2)
are from I. V. Oseledets, “Tensor-train decomposition” [34].
Theorem E.1.1. If for each unfolding matrix Ak of a d-dimensional tensor A
rank(Ak) = rk, (E.1)
then there exists a decomposition (equation 6.2) with TT-ranks not higher than rk.
Theorem E.1.2. Suppose that the unfoldings Ak of the tensor A satisfy: Ak = Rk + Qk, rank(Rk) = rk,





Corollary E.1.2.1. If a tensor A admits a canonical approximation with R terms and accuracy ε, then
there exists a TT-approximation with TT-ranks rk ≤ R and accuracy
√
d− 1ε.
Corollary E.1.2.2. Given a tensor A and rank bounds rk, the best approximation to A in the Frobenius
norm with TT-ranks bounded by rk always exists (denote it by A
best), and the TT-approximation B computed
by the TT-SVD algorithm is quasi-optimal:
‖A−B‖F ≤
√
d− 1‖A−Abest‖F . (E.3)
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E.2 Supplementary figures
Figure E.1: The cross entropy loss vs epochs of each SP1 CNN-TT model configuration. (A) The
cross entropy loss vs epochs of the CNN-TT model with configuration (r0, r1, r2, r3) = (1, 4, 4, 1) and
(m1,m2,m3) × (n1, n2, n3) = (4, 4, 5) × (4, 4, 60). The total parameter number is 4861. The training
was stopped and the trained model was retrieved at epoch 700. (B) Similar to (A), but for configuration
(r0, r1, r2, r3) = (1, 8, 8, 1) and (m1,m2,m3) × (n1, n2, n3) = (4, 4, 5) × (4, 4, 60). The total parameter
number is 6893. The training was stopped and the trained model was retrieved at epoch 230.
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Figure E.2: The core motif learned by the CNN-TT model resembled the core motif of SP1 MA0079.3.
(A) One of the motifs learned by the CNN-TT model with configuration (r0, r1, r2, r3) = (1, 8, 8, 1) and
(m1,m2,m3)× (n1, n2, n3) = (4, 4, 5)× (4, 4, 60) (total parameter number 6893), visualized through a motif
logo obtained from WebLogo [79] 3. The core motif inside the red box resembles the core motif of SP1
MA0079.3 (Figure 4.3A). (B) The motif learned by the original CNN model in Section 4.3. The learned
motif from the CNN-TT model resembles the learned motif from the original CNN model.
Figure E.3: Another motif learned by the CNN-TT model resembles the HNF4A motif MA0114.2.
(A) Another motif learned by the CNN-TT model with configuration (r0, r1, r2, r3) = (1, 8, 8, 1) and
(m1,m2,m3) × (n1, n2, n3) = (4, 4, 5) × (4, 4, 60) (total parameter number 6893), visualized through a mo-
tif logo obtained from WebLogo [79] 3. (B) The motif logo of HNF4A MA0114.2 from the JASPAR [24]
database.
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